{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:48:58Z","timestamp":1792097338487,"version":"4.4.0"},"reference-count":256,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Key Project of Jiangxi Provincial Natural Science Foundation"},{"name":"National College Students\u2019 Innovative Entrepreneurial Training Plan Program"},{"name":"Innovation and Entrepreneurship Training Program for College Students in Jiangxi Province"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s10495-026-02459-z","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:02:40Z","timestamp":1792072960000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Platelets as non-canonical immune regulatory nodes: orchestrating T cell dysfunction and immunotherapy resistance in cancer"],"prefix":"10.1007","volume":"31","author":[{"given":"Qian","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoshui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahong","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4040-0327","authenticated-orcid":false,"given":"Jie","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7855-3308","authenticated-orcid":false,"given":"Liang","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"key":"2459_CR1","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll DM (2012) The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 12:252\u2013264","journal-title":"Nat Rev Cancer"},{"key":"2459_CR2","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1080\/21645515.2019.1571892","volume":"15","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, Chen M, Nie H, Yuan Y (2019) PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations. Hum Vaccin Immunother 15:1111\u20131122","journal-title":"Hum Vaccin Immunother"},{"key":"2459_CR3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","volume":"30","author":"X Ma","year":"2019","unstructured":"Ma X, Bi E, Lu Y, Su P, Huang C, Liu L, Wang Q, Yang M, Kalady MF, Qian J, Zhang A, Gupte AA, Hamilton DJ, Zheng C, Yi Q (2019) Cholesterol induces CD8(+) T cell exhaustion in the tumor microenvironment. Cell Metab 30:143-156.e5","journal-title":"Cell Metab"},{"key":"2459_CR4","first-page":"508","volume":"23","author":"T Chen","year":"2023","unstructured":"Chen T, Xue Y, Wang S, Lu J, Zhou H, Zhang W, Zhou Z, Li B, Li Y, Wang Z, Li C, Eloy Y, Sun H, Shen Y, Diarra MD, Ge C, Chai X, Mou H, Lin P, Yu X, Ye Z (2023) Enhancement of T cell infiltration via tumor-targeted Th9 cell delivery improves the efficacy of antitumor immunotherapy of solid tumors. Bioact Mater 23:508\u2013523","journal-title":"Bioact Mater"},{"key":"2459_CR5","doi-asserted-by":"publisher","first-page":"8151","DOI":"10.1038\/s41467-025-62878-5","volume":"16","author":"J Yang","year":"2025","unstructured":"Yang J, Wang C, Fu D, Ho LL, Galani K, Chen L, Gonzalez J, Fu J, Huang AY, Frederick DT, He L, Asnani M, Tacke R, Robitschek EJ, Yadav SK, Deng W, Burke KP, Sharova T, Sullivan RJ, Weiss S, Rai K, Liu D, Boland GM, Kellis M (2025) Mature and migratory dendritic cells promote immune infiltration and response to anti-PD-1 checkpoint blockade in metastatic melanoma. Nat Commun 16:8151","journal-title":"Nat Commun"},{"key":"2459_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004381","author":"W Guo","year":"2022","unstructured":"Guo W, Wu Z, Chen J, Guo S, You W, Wang S, Ma J, Wang H, Wang X, Wang H, Ma J, Yang Y, Tian Y, Shi Q, Gao T, Yi X, Li C (2022) Nanoparticle delivery of miR-21-3p sensitizes melanoma to anti-PD-1 immunotherapy by promoting ferroptosis. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2021-004381","journal-title":"J Immunother Cancer"},{"key":"2459_CR7","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1111\/j.1600-6143.2007.01958.x","volume":"7","author":"CN Morrell","year":"2007","unstructured":"Morrell CN, Sun H, Swaim AM, Baldwin WM 3rd (2007) Platelets an inflammatory force in transplantation. Am J Transplant 7:2447\u20132454","journal-title":"Am J Transplant"},{"key":"2459_CR8","volume":"13","author":"F Cognasse","year":"2022","unstructured":"Cognasse F, Duchez AC, Audoux E, Ebermeyer T, Arthaud CA, Prier A, Eyraud MA, Mismetti P, Garraud O, Bertoletti L, Hamzeh-Cognasse H (2022) Platelets as key factors in inflammation: focus on CD40L\/CD40. Front Immunol 13:825892","journal-title":"Front Immunol"},{"key":"2459_CR9","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1158\/0008-5472.CAN-04-0465","volume":"64","author":"PC Rodriguez","year":"2004","unstructured":"Rodriguez PC, Quiceno DG, Zabaleta J, Ortiz B, Zea AH, Piazuelo MB, Delgado A, Correa P, Brayer J, Sotomayor EM, Antonia S, Ochoa JB, Ochoa AC (2004) Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res 64:5839\u20135849","journal-title":"Cancer Res"},{"key":"2459_CR10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1703974","volume":"16","author":"C Locatelli","year":"2025","unstructured":"Locatelli C, Ferrario N, Fortunato O, Ghidotti P, Crescitelli R (2025) Platelets and platelet-derived extracellular vesicles: their role in lung cancer dissemination and premetastatic niche formation. Front Immunol 16:1703974","journal-title":"Front Immunol"},{"key":"2459_CR11","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1038\/s41467-021-23909-z","volume":"12","author":"M Lacy","year":"2021","unstructured":"Lacy M, B\u00fcrger C, Shami A, Ahmadsei M, Winkels H, Nitz K, van Tiel CM, Seijkens TTP, Kusters PJH, Karshovka E, Prange KHM, Wu Y, Brouns SLN, Unterlugauer S, Kuijpers MJE, Reiche ME, Steffens S, Edsfeldt A, Megens RTA, Heemskerk JWM, Goncalves I, Weber C, Gerdes N, Atzler D, Lutgens E (2021) Cell-specific and divergent roles of the CD40L-CD40 axis in atherosclerotic vascular disease. Nat Commun 12:3754","journal-title":"Nat Commun"},{"key":"2459_CR12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jprot.2014.02.008","volume":"101","author":"A Zufferey","year":"2014","unstructured":"Zufferey A, Schvartz D, Nolli S, Reny JL, Sanchez JC, Fontana P (2014) Characterization of the platelet granule proteome: evidence of the presence of MHC1 in alpha-granules. J Proteomics 101:130\u2013140","journal-title":"J Proteomics"},{"key":"2459_CR13","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ccell.2022.08.004","volume":"40","author":"C Ma","year":"2022","unstructured":"Ma C, Fu Q, Diggs LP, McVey JC, McCallen J, Wabitsch S, Ruf B, Brown Z, Heinrich B, Zhang Q, Rosato U, Wang S, Cui L, Berzofsky JA, Kleiner DE, Bosco DB, Wu LJ, Lai CW, Rotman Y, Xie C, Korangy F, Greten TF (2022) Platelets control liver tumor growth through P2Y12-dependent CD40L release in NAFLD. Cancer Cell 40:986-998.e5","journal-title":"Cancer Cell"},{"key":"2459_CR14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-11-1872","volume":"72","author":"T Placke","year":"2012","unstructured":"Placke T, \u00d6rgel M, Schaller M, Jung G, Rammensee HG, Kopp HG, Salih HR (2012) Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells. Cancer Res 72:440\u2013448","journal-title":"Cancer Res"},{"issue":"11","key":"2459_CR15","doi-asserted-by":"crossref","first-page":"eaai7911","DOI":"10.1126\/sciimmunol.aai7911","volume":"2","author":"S Rachidi","year":"2017","unstructured":"Rachidi S, Metelli A, Riesenberg B, Wu BX, Nelson MH, Wallace C, Paulos CM, Rubinstein MP, Garrett-Mayer E, Hennig M, Bearden DW, Yang Y, Liu B, Li Z (2017) Platelets subvert T cell immunity against cancer via GARP-TGF\u03b2 axis. Sci Immunol 2(11):eaai7911","journal-title":"Sci Immunol"},{"key":"2459_CR16","doi-asserted-by":"publisher","first-page":"7005","DOI":"10.1038\/s41467-021-27303-7","volume":"12","author":"C Hinterleitner","year":"2021","unstructured":"Hinterleitner C, Str\u00e4hle J, Malenke E, Hinterleitner M, Henning M, Seehawer M, Bilich T, Heitmann J, Lutz M, Mattern S, Scheuermann S, Horger M, Maurer S, Walz J, Fend F, Handgretinger R, Seitz C, Weigelin B, Singer S, Salih H, Borst O, Kopp HG, Zender L (2021) Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancer. Nat Commun 12:7005","journal-title":"Nat Commun"},{"key":"2459_CR17","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.ccell.2023.02.005","volume":"41","author":"JD Klement","year":"2023","unstructured":"Klement JD, Redd PS, Lu C, Merting AD, Poschel DB, Yang D, Savage NM, Zhou G, Munn DH, Fallon PG, Liu K (2023) Tumor PD-L1 engages myeloid PD-1 to suppress type I interferon to impair cytotoxic T lymphocyte recruitment. Cancer Cell 41:620-636.e9","journal-title":"Cancer Cell"},{"key":"2459_CR18","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5482\/hamo-14-11-0065","volume":"35","author":"E Mammadova-Bach","year":"2015","unstructured":"Mammadova-Bach E, Mangin P, Lanza F, Gachet C (2015) Platelets in cancer. From basic research to therapeutic implications. Hamostaseologie 35:325\u2013336","journal-title":"Hamostaseologie"},{"key":"2459_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13045-022-01292-6","volume":"15","author":"Q Wu","year":"2022","unstructured":"Wu Q, You L, Nepovimova E, Heger Z, Wu W, Kuca K, Adam V (2022) Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape. J Hematol Oncol 15:77","journal-title":"J Hematol Oncol"},{"key":"2459_CR20","volume":"103","author":"S Tian","year":"2024","unstructured":"Tian S, Wang Y, Wan J, Yang M, Fu Z (2024) Co-stimulators CD40-CD40L, a potential immune-therapy target for atherosclerosis: a review. Medicine (Baltimore) 103:e37718","journal-title":"Medicine (Baltimore)"},{"key":"2459_CR21","volume":"13","author":"Y Li","year":"2023","unstructured":"Li Y, Xiang S, Pan W, Wang J, Zhan H, Liu S (2023) Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: current research and future perspective. Front Oncol 13:1166860","journal-title":"Front Oncol"},{"key":"2459_CR22","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112131","volume":"42","author":"K Hoeft","year":"2023","unstructured":"Hoeft K, Schaefer GJL, Kim H, Schumacher D, Bleckwehl T, Long Q, Klinkhammer BM, Peisker F, Koch L, Nagai J, Halder M, Ziegler S, Liehn E, Kuppe C, Kranz J, Menzel S, Costa I, Wahida A, Boor P, Schneider RK, Hayat S, Kramann R (2023) Platelet-instructed SPP1(+) macrophages drive myofibroblast activation in fibrosis in a CXCL4-dependent manner. Cell Rep 42:112131","journal-title":"Cell Rep"},{"key":"2459_CR23","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.2147\/DDDT.S72394","volume":"8","author":"M Akhavanpoor","year":"2014","unstructured":"Akhavanpoor M, Gleissner CA, Gorbatsch S, Doesch AO, Akhavanpoor H, Wangler S, Jahn F, Lasitschka F, Katus HA, Erbel C (2014) CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions. Drug Des Devel Ther 8:2359\u20132371","journal-title":"Drug Des Devel Ther"},{"key":"2459_CR24","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1110352","volume":"366","author":"RL Stone","year":"2012","unstructured":"Stone RL, Nick AM, McNeish IA, Balkwill F, Han HD, Bottsford-Miller J, Rupairmoole R, Armaiz-Pena GN, Pecot CV, Coward J, Deavers MT, Vasquez HG, Urbauer D, Landen CN, Hu W, Gershenson H, Matsuo K, Shahzad MM, King ER, Tekedereli I, Ozpolat B, Ahn EH, Bond VK, Wang R, Drew AF, Gushiken F, Lamkin D, Collins K, DeGeest K, Lutgendorf SK, Chiu W, Lopez-Berestein G, Afshar-Kharghan V, Sood AK (2012) Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med 366:610\u2013618","journal-title":"N Engl J Med"},{"key":"2459_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13045-018-0669-2","volume":"11","author":"M Schlesinger","year":"2018","unstructured":"Schlesinger M (2018) Role of platelets and platelet receptors in cancer metastasis. J Hematol Oncol 11:125","journal-title":"J Hematol Oncol"},{"key":"2459_CR26","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2141.2004.05032.x","volume":"126","author":"P Andr\u00e9","year":"2004","unstructured":"Andr\u00e9 P (2004) P-selectin in haemostasis. Br J Haematol 126:298\u2013306","journal-title":"Br J Haematol"},{"key":"2459_CR27","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1083\/jcb.101.3.880","volume":"101","author":"PE Stenberg","year":"1985","unstructured":"Stenberg PE, McEver RP, Shuman MA, Jacques YV, Bainton DF (1985) A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol 101:880\u2013886","journal-title":"J Cell Biol"},{"key":"2459_CR28","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1160\/TH05-07-0524","volume":"95","author":"A Solpov","year":"2006","unstructured":"Solpov A, Shenkman B, Vitkovsky Y, Brill G, Koltakov A, Farzam N, Varon D, Bank I, Savion N (2006) Platelets enhance CD4+ lymphocyte adhesion to extracellular matrix under flow conditions: role of platelet aggregation, integrins, and non-integrin receptors. Thromb Haemost 95:815\u2013821","journal-title":"Thromb Haemost"},{"key":"2459_CR29","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.immuni.2016.04.015","volume":"44","author":"R Tinoco","year":"2016","unstructured":"Tinoco R, Carrette F, Barraza ML, Otero DC, Maga\u00f1a J, Bosenberg MW, Swain SL, Bradley LM (2016) PSGL-1 is an immune checkpoint regulator that promotes T cell exhaustion. Immunity 44:1190\u20131203","journal-title":"Immunity"},{"key":"2459_CR30","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1158\/2767-9764.CRC-26-0187","volume":"6","author":"MR Smith-Oliver","year":"2026","unstructured":"Smith-Oliver MR, Gautam D, Petrarca GC, Sullivan ME, Clarke EM, Goggi G, Spasic M, Kane N, Brown J, Roweth HG, Baginska J, Garrido-Castro AC, Davenport P, McAllister SS, Battinelli EM (2026) Tumor-associated platelets suppress T-cell function and promote immune evasion in TNBC via the P-selectin\/P-selectin glycoprotein ligand 1 pathway. Cancer Res Commun 6:1640\u20131655","journal-title":"Cancer Res Commun"},{"key":"2459_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010193","author":"SW Lee","year":"2025","unstructured":"Lee SW, Jeong S, Kim YJ, Noh JE, Rho KN, Kim HO, Cho HJ, Yang DH, Hwang EC, Bae WK, Yun SJ, Yun JS, Park CK, Oh IJ, Cho JH (2025) Enhanced thrombopoiesis supplies PD-L1 to circulating immune cells via the generation of PD-L1-expressing platelets in patients with lung cancer. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2024-010193","journal-title":"J Immunother Cancer"},{"key":"2459_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76351-4","volume":"10","author":"AB Zaslavsky","year":"2020","unstructured":"Zaslavsky AB, Adams MP, Cao X, Maj T, Choi JE, Stangl-Kremser J, Patel S, Putelo A, Lee SK, Nallandhighal S, Kasputis A, Alva A, Lew M, Qin A, Mehra R, Morgan TM, Salami SS, Reichert Z, Udager A, Zou W, Palapattu GS (2020) Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors. Sci Rep 10:19296","journal-title":"Sci Rep"},{"key":"2459_CR33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-981-15-3266-5_3","volume":"1248","author":"L Ai","year":"2020","unstructured":"Ai L, Xu A, Xu J (2020) Roles of PD-1\/PD-L1 pathway: signaling, cancer, and beyond. Adv Exp Med Biol 1248:33\u201359","journal-title":"Adv Exp Med Biol"},{"key":"2459_CR34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12964-025-02034-0","volume":"23","author":"J Li","year":"2025","unstructured":"Li J, Liu J, Yang S, Xia Y, Meng Q, Sun B, Liu Y, Zhao B, Jin J, Xu H, Wang L, Zhang P, Cheng Z (2025) PD-L1 positive platelets mediate resistance to immune checkpoint inhibitors in patients with colorectal cancer. Cell Commun Signal 23:29","journal-title":"Cell Commun Signal"},{"key":"2459_CR35","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1002\/eji.200737766","volume":"37","author":"MC Fantini","year":"2007","unstructured":"Fantini MC, Rizzo A, Fina D, Caruso R, Becker C, Neurath MF, Macdonald TT, Pallone F, Monteleone G (2007) IL-21 regulates experimental colitis by modulating the balance between Treg and Th17 cells. Eur J Immunol 37:3155\u20133163","journal-title":"Eur J Immunol"},{"key":"2459_CR36","doi-asserted-by":"crossref","first-page":"7112","DOI":"10.4049\/jimmunol.180.11.7112","volume":"180","author":"SG Zheng","year":"2008","unstructured":"Zheng SG, Wang J, Horwitz DA (2008) Cutting edge: Foxp3+CD4+CD25+ regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17 conversion by IL-6. J Immunol 180:7112\u20137116","journal-title":"J Immunol"},{"key":"2459_CR37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4049\/jimmunol.0801986","volume":"183","author":"H Qin","year":"2009","unstructured":"Qin H, Wang L, Feng T, Elson CO, Niyongere SA, Lee SJ, Reynolds SL, Weaver CT, Roarty K, Serra R, Benveniste EN, Cong Y (2009) TGF-beta promotes Th17 cell development through inhibition of SOCS3. J Immunol 183:97\u2013105","journal-title":"J Immunol"},{"key":"2459_CR38","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1042\/BST20140322","volume":"43","author":"M Dovizio","year":"2015","unstructured":"Dovizio M, Alberti S, Sacco A, Guillem-Llobat P, Schiavone S, Maier TJ, Steinhilber D, Patrignani P (2015) Novel insights into the regulation of cyclooxygenase-2 expression by platelet-cancer cell cross-talk. Biochem Soc Trans 43:707\u2013714","journal-title":"Biochem Soc Trans"},{"key":"2459_CR39","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41586-024-07254-x","volume":"629","author":"SB Lacher","year":"2024","unstructured":"Lacher SB, D\u00f6rr J, de Almeida GP, H\u00f6nninger J, Bayerl F, Hirschberger A, Pedde AM, Meiser P, Ramsauer L, Rudolph TJ, Spranger N, Morotti M, Grimm AJ, Jarosch S, Oner A, Gregor L, Lesch S, Michaelides S, Fertig L, Briukhovetska D, Majed L, Stock S, Busch DH, Buchholz VR, Knolle PA, Zehn D, Dangaj Laniti D, Kobold S, B\u00f6ttcher JP (2024) PGE(2) limits effector expansion of tumour-infiltrating stem-like CD8(+) T cells. Nature 629:417\u2013425","journal-title":"Nature"},{"key":"2459_CR40","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41586-024-07352-w","volume":"629","author":"M Morotti","year":"2024","unstructured":"Morotti M, Grimm AJ, Hope HC, Arnaud M, Desbuisson M, Rayroux N, Barras D, Masid M, Murgues B, Chap BS, Ongaro M, Rota IA, Ronet C, Minasyan A, Chiffelle J, Lacher SB, Bobisse S, Murgues C, Ghisoni E, Ouchen K, Bou Mjahed R, Benedetti F, Abdellaoui N, Turrini R, Gannon PO, Zaman K, Mathevet P, Lelievre L, Crespo I, Conrad M, Verdeil G, Kandalaft LE, Dagher J, Corria-Osorio J, Doucey MA, Ho PC, Harari A, Vannini N, B\u00f6ttcher JP, Dangaj Laniti D, Coukos G (2024) PGE(2) inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function. Nature 629:426\u2013434","journal-title":"Nature"},{"key":"2459_CR41","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.canlet.2020.06.014","volume":"491","author":"M Mulet","year":"2020","unstructured":"Mulet M, Zamora C, Porcel JM, Nieto JC, Pajares V, Mu\u00f1oz-Fernandez AM, Calvo N, Esquerda A, Vidal S (2020) Platelet factor 4 regulates T cell effector functions in malignant pleural effusions. Cancer Lett 491:78\u201386","journal-title":"Cancer Lett"},{"key":"2459_CR42","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.631285","volume":"12","author":"A Saris","year":"2021","unstructured":"Saris A, Steuten J, Schrijver DP, van Schijndel G, Zwaginga JJ, van Ham SM, Ten Brinke A (2021) Inhibition of dendritic cell activation and modulation of T cell polarization by the platelet secretome. Front Immunol 12:631285","journal-title":"Front Immunol"},{"key":"2459_CR43","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1111\/jth.15005","volume":"18","author":"S Tan","year":"2020","unstructured":"Tan S, Li S, Min Y, Gister\u00e5 A, Moruzzi N, Zhang J, Sun Y, Andersson J, Malmstr\u00f6m RE, Wang M, Berggren PO, Schlisio S, Liao W, Ketelhuth DFJ, Ma C, Li N (2020) Platelet factor 4 enhances CD4(+) T effector memory cell responses via Akt-PGC1\u03b1-TFAM signaling-mediated mitochondrial biogenesis. Journal of thrombosis and haemostasis: JTH 18:2685\u20132700","journal-title":"Journal of thrombosis and haemostasis: JTH"},{"key":"2459_CR44","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1080\/09537104.2021.1936479","volume":"33","author":"S Tan","year":"2022","unstructured":"Tan S, Zhang J, Sun Y, Gister\u00e5 A, Sheng Z, Malmstr\u00f6m RE, Hou M, Peng J, Ma C, Liao W, Li N (2022) Platelets enhance CD4+ central memory T cell responses via platelet factor 4-dependent mitochondrial biogenesis and cell proliferation. Platelets 33:360\u2013370","journal-title":"Platelets"},{"key":"2459_CR45","doi-asserted-by":"crossref","first-page":"27725","DOI":"10.18632\/oncotarget.9486","volume":"8","author":"J Jian","year":"2017","unstructured":"Jian J, Pang Y, Yan HH, Min Y, Achyut BR, Hollander MC, Lin PC, Liang X, Yang L (2017) Platelet factor 4 is produced by subsets of myeloid cells in premetastatic lung and inhibits tumor metastasis. Oncotarget 8:27725\u201327739","journal-title":"Oncotarget"},{"issue":"525","key":"2459_CR46","doi-asserted-by":"crossref","first-page":"eaay4860","DOI":"10.1126\/scitranslmed.aay4860","volume":"12","author":"A Metelli","year":"2020","unstructured":"Metelli A, Wu BX, Riesenberg B, Guglietta S, Huck JD, Mills C, Li A, Rachidi S, Krieg C, Rubinstein MP, Gewirth DT, Sun S, Lilly MB, Wahlquist AH, Carbone DP, Yang Y, Liu B, Li Z (2020) Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-\u03b2. Sci Transl Med 12(525):eaay4860","journal-title":"Sci Transl Med"},{"key":"2459_CR47","doi-asserted-by":"crossref","first-page":"9464","DOI":"10.1038\/s41467-024-53706-3","volume":"15","author":"S Punyawatthananukool","year":"2024","unstructured":"Punyawatthananukool S, Matsuura R, Wongchang T, Katsurada N, Tsuruyama T, Tajima M, Enomoto Y, Kitamura T, Kawashima M, Toi M, Yamanoi K, Hamanishi J, Hisamori S, Obama K, Charoensawan V, Thumkeo D, Narumiya S (2024) Prostaglandin E(2)-EP2\/EP4 signaling induces immunosuppression in human cancer by impairing bioenergetics and ribosome biogenesis in immune cells. Nat Commun 15:9464","journal-title":"Nat Commun"},{"key":"2459_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12123653","author":"N Zimmer","year":"2020","unstructured":"Zimmer N, Krebs FK, Zimmer S, Mitzel-Rink H, Kumm EJ, Jurk K, Grabbe S, Loquai C, Tuettenberg A (2020) Platelet-derived GARP induces peripheral regulatory T cells-potential impact on T cell suppression in patients with melanoma-associated thrombocytosis. Cancers. https:\/\/doi.org\/10.3390\/cancers12123653","journal-title":"Cancers"},{"key":"2459_CR49","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.4049\/jimmunol.172.9.5149","volume":"172","author":"MC Fantini","year":"2004","unstructured":"Fantini MC, Becker C, Monteleone G, Pallone F, Galle PR, Neurath MF (2004) Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 172:5149\u20135153","journal-title":"J Immunol"},{"key":"2459_CR50","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.it.2010.04.002","volume":"31","author":"L Yang","year":"2010","unstructured":"Yang L, Pang Y, Moses HL (2010) TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression. Trends Immunol 31:220\u2013227","journal-title":"Trends Immunol"},{"key":"2459_CR51","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1355769","volume":"15","author":"J Cuenca-Escalona","year":"2024","unstructured":"Cuenca-Escalona J, Subtil B, Garcia-Perez A, Cambi A, de Vries IJM, Fl\u00f3rez-Grau G (2024) EP2 and EP4 blockade prevents tumor-induced suppressive features in human monocytic myeloid-derived suppressor cells. Front Immunol 15:1355769","journal-title":"Front Immunol"},{"key":"2459_CR52","volume":"57","author":"C Lou","year":"2025","unstructured":"Lou C, Cai X (2025) The emerging roles of platelet-derived extracellular vesicles in disease. Ann Med 57:2499029","journal-title":"Ann Med"},{"key":"2459_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241210275","author":"X Li","year":"2023","unstructured":"Li X, Wang Q (2023) Platelet-derived microparticles and autoimmune diseases. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241210275","journal-title":"Int J Mol Sci"},{"key":"2459_CR54","volume":"19","author":"J Guo","year":"2024","unstructured":"Guo J, Cui B, Zheng J, Yu C, Zheng X, Yi L, Zhang S, Wang K (2024) Platelet-derived microparticles and their cargos: the past, present and future. Asian J Pharm Sci 19:100907","journal-title":"Asian J Pharm Sci"},{"key":"2459_CR55","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1160\/th14-03-0281","volume":"112","author":"S Sadallah","year":"2014","unstructured":"Sadallah S, Amicarella F, Eken C, Iezzi G, Schifferli JA (2014) Ectosomes released by platelets induce differentiation of CD4+T cells into T regulatory cells. Thromb Haemost 112:1219\u20131229","journal-title":"Thromb Haemost"},{"key":"2459_CR56","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1182\/blood-2015-04-640300","volume":"127","author":"S Dinkla","year":"2016","unstructured":"Dinkla S, van Cranenbroek B, van der Heijden WA, He X, Wallbrecher R, Dumitriu IE, van der Ven AJ, Bosman GJ, Koenen HJ, Joosten I (2016) Platelet microparticles inhibit IL-17 production by regulatory T cells through P-selectin. Blood 127:1976\u20131986","journal-title":"Blood"},{"key":"2459_CR57","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/10641963.2018.1510941","volume":"41","author":"Y Yang","year":"2019","unstructured":"Yang Y, Luo H, Liu S, Zhang R, Zhu X, Liu M, Hu H, Yang Y, Lv Z, Chen M (2019) Platelet microparticles-containing miR-4306 inhibits human monocyte-derived macrophages migration through VEGFA\/ERK1\/2\/NF-\u03baB signaling pathways. Clin Exp Hypertens 41:481\u2013491","journal-title":"Clin Exp Hypertens"},{"key":"2459_CR58","volume":"7","author":"R Yao","year":"2012","unstructured":"Yao R, Ma YL, Liang W, Li HH, Ma ZJ, Yu X, Liao YH (2012) MicroRNA-155 modulates Treg and Th17 cells differentiation and Th17 cell function by targeting SOCS1. PLoS ONE 7:e46082","journal-title":"PLoS ONE"},{"key":"2459_CR59","doi-asserted-by":"crossref","first-page":"11208","DOI":"10.1182\/blood-2022-170261","volume":"140","author":"AK Hubben","year":"2022","unstructured":"Hubben AK, Shim YJ, Kundu S, Cameron SJ, McCrae KR (2022) Programmed death ligand 1 is released in platelet-derived extracellular vesicles. Blood 140:11208\u201311209","journal-title":"Blood"},{"key":"2459_CR60","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12964-021-00816-w","volume":"20","author":"J Liu","year":"2022","unstructured":"Liu J, Peng X, Yang S, Li X, Huang M, Wei S, Zhang S, He G, Zheng H, Fan Q, Yang L, Li H (2022) Extracellular vesicle PD-L1 in reshaping tumor immune microenvironment: biological function and potential therapy strategies. Cell Commun Signal 20:14","journal-title":"Cell Commun Signal"},{"key":"2459_CR61","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1111\/trf.17524","volume":"63","author":"M Pelletier","year":"2023","unstructured":"Pelletier M, Breton Y, Allaeys I, Becker Y, Benson T, Boilard E (2023) Platelet extracellular vesicles and their mitochondrial content improve the mitochondrial bioenergetics of cellular immune recipients. Transfusion 63:1983\u20131996","journal-title":"Transfusion"},{"key":"2459_CR62","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1016\/j.jtha.2025.08.004","volume":"23","author":"HE Allan","year":"2025","unstructured":"Allan HE, Dark N, Vulliamy P, Crescente M, Maffucci T, Armstrong PC, Ferreira P, Warner TD (2025) Platelet mitochondrial transfer via extracellular vesicles modulates neutrophil phenotype and function. J Thromb Haemost 23:3665\u20133677","journal-title":"J Thromb Haemost"},{"key":"2459_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2026.06.032","author":"F Farhid","year":"2026","unstructured":"Farhid F, Heydari F, Hamblin MR, Masoudifar S, Sahebkar A, Naghinezhad J (2026) Intercellular mitochondrial transfer and mitochondrial transplantation in cardiovascular disease. Can J Cardiol. https:\/\/doi.org\/10.1016\/j.cjca.2026.06.032","journal-title":"Can J Cardiol"},{"key":"2459_CR64","doi-asserted-by":"crossref","first-page":"e55185","DOI":"10.7554\/eLife.55185","volume":"9","author":"AR Lim","year":"2020","unstructured":"Lim AR, Rathmell WK, Rathmell JC (2020) The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy. Elife 9:e55185","journal-title":"Elife"},{"key":"2459_CR65","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jconrel.2014.07.049","volume":"195","author":"R van der Meel","year":"2014","unstructured":"van der Meel R, Fens MH, Vader P, van Solinge WW, Eniola-Adefeso O, Schiffelers RM (2014) Extracellular vesicles as drug delivery systems: lessons from the liposome field. J Control Release 195:72\u201385","journal-title":"J Control Release"},{"key":"2459_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0965-7","volume":"18","author":"S Maacha","year":"2019","unstructured":"Maacha S, Bhat AA, Jimenez L, Raza A, Haris M, Uddin S, Grivel JC (2019) Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance. Mol Cancer 18:55","journal-title":"Mol Cancer"},{"issue":"6478","key":"2459_CR67","doi-asserted-by":"crossref","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS (2020) The biology, function, and biomedical applications of exosomes. Science 367(6478):eaau6977","journal-title":"Science"},{"key":"2459_CR68","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1158\/2326-6066.CIR-21-0690","volume":"10","author":"JM DeRogatis","year":"2022","unstructured":"DeRogatis JM, Viramontes KM, Neubert EN, Henriquez ML, Guerrero-Juarez CF, Tinoco R (2022) Targeting the PSGL-1 immune checkpoint promotes immunity to PD-1-resistant melanoma. Cancer Immunol Res 10:612\u2013625","journal-title":"Cancer Immunol Res"},{"key":"2459_CR69","doi-asserted-by":"publisher","first-page":"4545","DOI":"10.1038\/s41467-020-17811-3","volume":"11","author":"G de Streel","year":"2020","unstructured":"de Streel G, Bertrand C, Chalon N, Li\u00e9nart S, Bricard O, Lecomte S, Devreux J, Gaignage M, De Boeck G, Mari\u00ebn L, Van De Walle I, van der Woning B, Saunders M, de Haard H, Vermeersch E, Maes W, Deckmyn H, Coulie PG, van Baren N, Lucas S (2020) Selective inhibition of TGF-\u03b21 produced by GARP-expressing Tregs overcomes resistance to PD-1\/PD-L1 blockade in cancer. Nat Commun 11:4545","journal-title":"Nat Commun"},{"key":"2459_CR70","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1158\/2159-8290.CD-20-1815","volume":"11","author":"VS Pelly","year":"2021","unstructured":"Pelly VS, Moeini A, Roelofsen LM, Bonavita E, Bell CR, Hutton C, Blanco-Gomez A, Banyard A, Bromley CP, Flanagan E, Chiang SC, J\u00f8rgensen C, Schumacher TN, Thommen DS, Zelenay S (2021) Anti-inflammatory drugs remodel the tumor immune environment to enhance immune checkpoint blockade efficacy. Cancer Discov 11:2602\u20132619","journal-title":"Cancer Discov"},{"key":"2459_CR71","volume":"321","author":"C Yao","year":"2025","unstructured":"Yao C, Ma Q, Wang H, Wu B, Dai H, Xu J, Bai J, Xu F, Dube A, Wang C (2025) Targeting myeloid cells with platelet-derived extracellular vesicles to overcome resistance of immune checkpoint blockade therapy. Biomaterials 321:123336","journal-title":"Biomaterials"},{"key":"2459_CR72","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.bbamcr.2015.07.008","volume":"1863","author":"M Yan","year":"2016","unstructured":"Yan M, Jurasz P (2016) The role of platelets in the tumor microenvironment: from solid tumors to leukemia. Biochim Biophys Acta 1863:392\u2013400","journal-title":"Biochim Biophys Acta"},{"key":"2459_CR73","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/jcp.25081","volume":"231","author":"C Yu","year":"2016","unstructured":"Yu C, Zhang S, Wang Y, Zhang S, Luo L, Thorlacius H (2016) Platelet-derived CCL5 regulates CXC chemokine formation and neutrophil recruitment in acute experimental colitis. J Cell Physiol 231:370\u2013376","journal-title":"J Cell Physiol"},{"key":"2459_CR74","doi-asserted-by":"crossref","first-page":"317ra196","DOI":"10.1126\/scitranslmed.aad5330","volume":"7","author":"JE Alard","year":"2015","unstructured":"Alard JE, Ortega-Gomez A, Wichapong K, Bongiovanni D, Horckmans M, Megens RT, Leoni G, Ferraro B, Rossaint J, Paulin N, Ng J, Ippel H, Suylen D, Hinkel R, Blanchet X, Gaillard F, D\u2019Amico M, von Hundelshausen P, Zarbock A, Scheiermann C, Hackeng TM, Steffens S, Kupatt C, Nicolaes GA, Weber C, Soehnlein O (2015) Recruitment of classical monocytes can be inhibited by disturbing heteromers of neutrophil HNP1 and platelet CCL5. Sci Transl Med 7:317ra196","journal-title":"Sci Transl Med"},{"key":"2459_CR75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2018.11.017","volume":"443","author":"S Deng","year":"2019","unstructured":"Deng S, Deng Q, Zhang Y, Ye H, Yu X, Zhang Y, Han GY, Luo P, Wu M, Yu Y, Han W (2019) Non-platelet-derived CXCL4 differentially regulates cytotoxic and regulatory T cells through CXCR3 to suppress the immune response to colon cancer. Cancer Lett 443:1\u201312","journal-title":"Cancer Lett"},{"key":"2459_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19030869","author":"CR Lee","year":"2018","unstructured":"Lee CR, Lee W, Cho SK, Park SG (2018) Characterization of multiple cytokine combinations and TGF-\u03b2 on differentiation and functions of myeloid-derived suppressor cells. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19030869","journal-title":"Int J Mol Sci"},{"key":"2459_CR77","doi-asserted-by":"crossref","first-page":"5243","DOI":"10.1158\/1078-0432.CCR-07-0182","volume":"13","author":"JE Talmadge","year":"2007","unstructured":"Talmadge JE (2007) Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy. Clin Cancer Res 13:5243\u20135248","journal-title":"Clin Cancer Res"},{"key":"2459_CR78","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1016\/j.celrep.2016.11.062","volume":"17","author":"CR Lee","year":"2016","unstructured":"Lee CR, Kwak Y, Yang T, Han JH, Park SH, Ye MB, Lee W, Sim KY, Kang JA, Kim YC, Mazmanian SK, Park SG (2016) Myeloid-derived suppressor cells are controlled by regulatory T cells via TGF-\u03b2 during murine colitis. Cell Rep 17:3219\u20133232","journal-title":"Cell Rep"},{"key":"2459_CR79","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s12032-025-02787-1","volume":"42","author":"SO Rab","year":"2025","unstructured":"Rab SO, Altalbawy FMA, Bishoyi AK, Ballal S, Kareem M, Singh A, Kubaev A, Soleimani Samarkhazan H, Bagheri S (2025) Targeting platelet-tumor cell interactions: a novel approach to cancer therapy. Med Oncol 42:232","journal-title":"Med Oncol"},{"key":"2459_CR80","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1158\/0008-5472.CAN-12-1875","volume":"73","author":"C Pe\u00f1a","year":"2013","unstructured":"Pe\u00f1a C, C\u00e9spedes MV, Lindh MB, Kiflemariam S, Mezheyeuski A, Edqvist PH, H\u00e4ggl\u00f6f C, Birgisson H, Bojmar L, Jirstr\u00f6m K, Sandstr\u00f6m P, Olsson E, Veerla S, Gallardo A, Sj\u00f6blom T, Chang AC, Reddel RR, Mangues R, Augsten M, Ostman A (2013) STC1 expression by cancer-associated fibroblasts drives metastasis of colorectal cancer. Cancer Res 73:1287\u20131297","journal-title":"Cancer Res"},{"key":"2459_CR81","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41389-018-0085-z","volume":"7","author":"A Herrera","year":"2018","unstructured":"Herrera A, Herrera M, Guerra-Perez N, Galindo-Pumari\u00f1o C, Larriba MJ, Garc\u00eda-Barber\u00e1n V, Gil B, Gim\u00e9nez-Moyano S, Ferreiro-Monteagudo R, Veguillas P, Candia A, Pe\u00f1a R, Pinto J, Garc\u00eda-Bermejo ML, Mu\u00f1oz A, Garc\u00eda de Herreros A, Bonilla F, Carrato A, Pe\u00f1a C (2018) Endothelial cell activation on 3D-matrices derived from PDGF-BB-stimulated fibroblasts is mediated by Snail1. Oncogenesis 7:76","journal-title":"Oncogenesis"},{"key":"2459_CR82","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.celrep.2015.06.024","volume":"12","author":"E Chun","year":"2015","unstructured":"Chun E, Lavoie S, Michaud M, Gallini CA, Kim J, Soucy G, Odze R, Glickman JN, Garrett WS (2015) CCL2 promotes colorectal carcinogenesis by enhancing polymorphonuclear myeloid-derived suppressor cell population and function. Cell Rep 12:244\u2013257","journal-title":"Cell Rep"},{"key":"2459_CR83","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jbo.2018.01.002","volume":"11","author":"Y Wang","year":"2018","unstructured":"Wang Y, Zhang X, Yang L, Xue J, Hu G (2018) Blockade of CCL2 enhances immunotherapeutic effect of anti-PD1 in lung cancer. J Bone Oncol 11:27\u201332","journal-title":"J Bone Oncol"},{"key":"2459_CR84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260124","volume":"16","author":"EP Darga","year":"2021","unstructured":"Darga EP, Dolce EM, Fang F, Kidwell KM, Gersch CL, Kregel S, Thomas DG, Gill A, Brown ME, Gross S, Connelly M, Holinstat M, Cobain EF, Rae JM, Hayes DF, Paoletti C (2021) PD-L1 expression on circulating tumor cells and platelets in patients with metastatic breast cancer. PLoS ONE 16:e0260124","journal-title":"PLoS ONE"},{"key":"2459_CR85","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.immuni.2023.09.005","volume":"56","author":"JR Giles","year":"2023","unstructured":"Giles JR, Globig AM, Kaech SM, Wherry EJ (2023) CD8(+) T cells in the cancer-immunity cycle. Immunity 56:2231\u20132253","journal-title":"Immunity"},{"key":"2459_CR86","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/s41467-020-15404-8","volume":"11","author":"AJ Gunderson","year":"2020","unstructured":"Gunderson AJ, Yamazaki T, McCarty K, Fox N, Phillips M, Alice A, Blair T, Whiteford M, O\u2019Brien D, Ahmad R, Kiely MX, Hayman A, Crocenzi T, Gough MJ, Crittenden MR, Young KH (2020) TGF\u03b2 suppresses CD8(+) T cell expression of CXCR3 and tumor trafficking. Nat Commun 11:1749","journal-title":"Nat Commun"},{"issue":"1","key":"2459_CR87","doi-asserted-by":"crossref","first-page":"e20212218","DOI":"10.1084\/jem.20212218","volume":"220","author":"T Tyagi","year":"2023","unstructured":"Tyagi T, Jain K, Yarovinsky TO, Chiorazzi M, Du J, Castro C, Griffin J, Korde A, Martin KA, Takyar SS, Flavell RA, Patel AA, Hwa J (2023) Platelet-derived TLT-1 promotes tumor progression by suppressing CD8+ T cells. J Exp Med 220(1):e20212218","journal-title":"J Exp Med"},{"key":"2459_CR88","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/bs.apha.2022.12.001","volume":"97","author":"A Bruno","year":"2023","unstructured":"Bruno A, Tacconelli S, Contursi A, Ballerini P, Patrignani P (2023) Cyclooxygenases and platelet functions. Adv Pharmacol 97:133\u2013165","journal-title":"Adv Pharmacol"},{"key":"2459_CR89","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","volume":"6","author":"B Wang","year":"2021","unstructured":"Wang B, Wu L, Chen J, Dong L, Chen C, Wen Z, Hu J, Fleming I, Wang DW (2021) Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets. Signal Transduct Target Ther 6:94","journal-title":"Signal Transduct Target Ther"},{"key":"2459_CR90","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mito.2017.10.006","volume":"41","author":"G Desd\u00edn-Mic\u00f3","year":"2018","unstructured":"Desd\u00edn-Mic\u00f3 G, Soto-Heredero G, Mittelbrunn M (2018) Mitochondrial activity in T cells. Mitochondrion 41:51\u201357","journal-title":"Mitochondrion"},{"key":"2459_CR91","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fimmu.2016.00222","volume":"7","author":"VL Wehbi","year":"2016","unstructured":"Wehbi VL, Task\u00e9n K (2016) Molecular mechanisms for cAMP-mediated immunoregulation in T cells - role of anchored protein kinase A signaling units. Front Immunol 7:222","journal-title":"Front Immunol"},{"key":"2459_CR92","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry EJ, Kurachi M (2015) Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol 15:486\u2013499","journal-title":"Nat Rev Immunol"},{"key":"2459_CR93","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.cell.2024.03.037","volume":"187","author":"H Chi","year":"2024","unstructured":"Chi H, Pepper M, Thomas PG (2024) Principles and therapeutic applications of adaptive immunity. Cell 187:2052\u20132078","journal-title":"Cell"},{"key":"2459_CR94","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00018-022-04279-1","volume":"79","author":"Y Min","year":"2022","unstructured":"Min Y, Hao L, Liu X, Tan S, Song H, Ni H, Sheng Z, Jooss N, Liu X, Malmstr\u00f6m RE, Sun Y, Liu J, Tang H, Zhang H, Ma C, Peng J, Hou M, Li N (2022) Platelets fine-tune effector responses of na\u00efve CD4(+) T cells via platelet factor 4-regulated transforming growth factor \u03b2 signaling. Cell Mol Life Sci 79:247","journal-title":"Cell Mol Life Sci"},{"key":"2459_CR95","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1172\/JCI71858","volume":"124","author":"G Shi","year":"2014","unstructured":"Shi G, Field DJ, Ko KA, Ture S, Srivastava K, Levy S, Kowalska MA, Poncz M, Fowell DJ, Morrell CN (2014) Platelet factor 4 limits Th17 differentiation and cardiac allograft rejection. J Clin Invest 124:543\u2013552","journal-title":"J Clin Invest"},{"key":"2459_CR96","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.4049\/jimmunol.165.9.4773","volume":"165","author":"L Gorelik","year":"2000","unstructured":"Gorelik L, Fields PE, Flavell RA (2000) Cutting edge: TGF-beta inhibits Th type 2 development through inhibition of GATA-3 expression. J Immunol 165:4773\u20134777","journal-title":"J Immunol"},{"key":"2459_CR97","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1084\/jem.20021170","volume":"197","author":"CH Chen","year":"2003","unstructured":"Chen CH, Seguin-Devaux C, Burke NA, Oriss TB, Watkins SC, Clipstone N, Ray A (2003) Transforming growth factor beta blocks Tec kinase phosphorylation, Ca2+ influx, and NFATc translocation causing inhibition of T cell differentiation. J Exp Med 197:1689\u20131699","journal-title":"J Exp Med"},{"key":"2459_CR98","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1084\/jem.20082286","volume":"206","author":"J Das","year":"2009","unstructured":"Das J, Ren G, Zhang L, Roberts AI, Zhao X, Bothwell AL, Van Kaer L, Shi Y, Das G (2009) Transforming growth factor beta is dispensable for the molecular orchestration of Th17 cell differentiation. J Exp Med 206:2407\u20132416","journal-title":"J Exp Med"},{"key":"2459_CR99","volume":"12","author":"EN Scott","year":"2021","unstructured":"Scott EN, Gocher AM, Workman CJ, Vignali DAA (2021) Regulatory T cells: barriers of immune infiltration into the tumor microenvironment. Front Immunol 12:702726","journal-title":"Front Immunol"},{"key":"2459_CR100","doi-asserted-by":"crossref","first-page":"13445","DOI":"10.1073\/pnas.0901944106","volume":"106","author":"DQ Tran","year":"2009","unstructured":"Tran DQ, Andersson J, Wang R, Ramsey H, Unutmaz D, Shevach EM (2009) GARP (LRRC32) is essential for the surface expression of latent TGF-beta on platelets and activated FOXP3+ regulatory T cells. Proc Natl Acad Sci USA 106:13445\u201313450","journal-title":"Proc Natl Acad Sci USA"},{"key":"2459_CR101","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.4049\/jimmunol.172.9.5213","volume":"172","author":"SG Zheng","year":"2004","unstructured":"Zheng SG, Wang JH, Gray JD, Soucier H, Horwitz DA (2004) Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10. J Immunol 172:5213\u20135221","journal-title":"J Immunol"},{"key":"2459_CR102","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1158\/0008-5472.CAN-18-2623","volume":"79","author":"M Salem","year":"2019","unstructured":"Salem M, Wallace C, Velegraki M, Li A, Ansa-Addo E, Metelli A, Kwon H, Riesenberg B, Wu B, Zhang Y, Guglietta S, Sun S, Liu B, Li Z (2019) GARP dampens cancer immunity by sustaining function and accumulation of regulatory T cells in the colon. Cancer Res 79:1178\u20131190","journal-title":"Cancer Res"},{"key":"2459_CR103","doi-asserted-by":"crossref","first-page":"7106","DOI":"10.1158\/0008-5472.CAN-16-1456","volume":"76","author":"A Metelli","year":"2016","unstructured":"Metelli A, Wu BX, Fugle CW, Rachidi S, Sun S, Zhang Y, Wu J, Tomlinson S, Howe PH, Yang Y, Garrett-Mayer E, Liu B, Li Z (2016) Surface expression of TGF\u03b2 docking receptor GARP promotes oncogenesis and immune tolerance in breast cancer. Cancer Res 76:7106\u20137117","journal-title":"Cancer Res"},{"key":"2459_CR104","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1189\/jlb.4A1214-603R","volume":"97","author":"R Hwaiz","year":"2015","unstructured":"Hwaiz R, Rahman M, Syk I, Zhang E, Thorlacius H (2015) Rac1-dependent secretion of platelet-derived CCL5 regulates neutrophil recruitment via activation of alveolar macrophages in septic lung injury. J Leukoc Biol 97:975\u2013984","journal-title":"J Leukoc Biol"},{"key":"2459_CR105","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1158\/0008-5472.CAN-11-2493","volume":"72","author":"LY Chang","year":"2012","unstructured":"Chang LY, Lin YC, Mahalingam J, Huang CT, Chen TW, Kang CW, Peng HM, Chu YY, Chiang JM, Dutta A, Day YJ, Chen TC, Yeh CT, Lin CY (2012) Tumor-derived chemokine CCL5 enhances TGF-\u03b2-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells. Cancer Res 72:1092\u20131102","journal-title":"Cancer Res"},{"key":"2459_CR106","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41418-024-01358-7","volume":"32","author":"S Dai","year":"2025","unstructured":"Dai S, Peng Y, Wang G, Chen C, Chen Q, Yin L, Yan H, Zhang K, Tu M, Lu Z, Wei J, Li Q, Wu J, Jiang K, Zhu Y, Miao Y (2025) LIM domain only 7: a novel driver of immune evasion through regulatory T cell differentiation and chemotaxis in pancreatic ductal adenocarcinoma. Cell Death Differ 32:271\u2013290","journal-title":"Cell Death Differ"},{"key":"2459_CR107","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41571-019-0175-7","volume":"16","author":"Y Togashi","year":"2019","unstructured":"Togashi Y, Shitara K, Nishikawa H (2019) Regulatory T cells in cancer immunosuppression: implications for anticancer therapy. Nat Rev Clin Oncol 16:356\u2013371","journal-title":"Nat Rev Clin Oncol"},{"key":"2459_CR108","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.immuni.2018.03.009","volume":"48","author":"DI Godfrey","year":"2018","unstructured":"Godfrey DI, Le Nours J, Andrews DM, Uldrich AP, Rossjohn J (2018) Unconventional T cell targets for cancer immunotherapy. Immunity 48:453\u2013473","journal-title":"Immunity"},{"key":"2459_CR109","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ccell.2024.11.010","volume":"43","author":"YR Li","year":"2025","unstructured":"Li YR, Zhou K, Zhu Y, Halladay T, Yang L (2025) Breaking the mold: unconventional T cells in cancer therapy. Cancer Cell 43:317\u2013322","journal-title":"Cancer Cell"},{"key":"2459_CR110","volume":"12","author":"J Luo","year":"2025","unstructured":"Luo J, Wang S, Yang Q, Fu Q, Zhu C, Li T, Yang S, Zhao Y, Guo R, Ben X, Zheng Y, Li S, Yang G, Zhang H, Xiao H, Jiang Z, Yan N, Kabelitz D, Sun G, Granot Z, Lu L, You F, Hao J, Yin Z (2025) \u03b3\u03b4 T cell-mediated tumor immunity is tightly regulated by STING and TGF-\u03b2 signaling pathways. Adv Sci 12:e2404432","journal-title":"Adv Sci"},{"key":"2459_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094492","author":"K Karolczak","year":"2021","unstructured":"Karolczak K, Watala C (2021) Blood platelets as an important but underrated circulating source of TGF\u03b2. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22094492","journal-title":"Int J Mol Sci"},{"key":"2459_CR112","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1186\/s12967-024-05327-z","volume":"22","author":"J Liu","year":"2024","unstructured":"Liu J, Wu M, Yang Y, Wang Z, He S, Tian X, Wang H (2024) \u03b3\u03b4 T cells and the PD-1\/PD-L1 axis: a love-hate relationship in the tumor microenvironment. J Transl Med 22:553","journal-title":"J Transl Med"},{"key":"2459_CR113","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.4049\/jimmunol.163.9.4647","volume":"163","author":"C Carnaud","year":"1999","unstructured":"Carnaud C, Lee D, Donnars O, Park SH, Beavis A, Koezuka Y, Bendelac A (1999) Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J Immunol 163:4647\u20134650","journal-title":"J Immunol"},{"key":"2459_CR114","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/intimm\/12.7.987","volume":"12","author":"T Nishimura","year":"2000","unstructured":"Nishimura T, Kitamura H, Iwakabe K, Yahata T, Ohta A, Sato M, Takeda K, Okumura K, Van Kaer L, Kawano T, Taniguchi M, Nakui M, Sekimoto M, Koda T (2000) The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes. Int Immunol 12:987\u2013994","journal-title":"Int Immunol"},{"key":"2459_CR115","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1084\/jem.20070458","volume":"204","author":"K Shimizu","year":"2007","unstructured":"Shimizu K, Kurosawa Y, Taniguchi M, Steinman RM, Fujii S (2007) Cross-presentation of glycolipid from tumor cells loaded with alpha-galactosylceramide leads to potent and long-lived T cell mediated immunity via dendritic cells. J Exp Med 204:2641\u20132653","journal-title":"J Exp Med"},{"key":"2459_CR116","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1600-065X.2007.00561.x","volume":"220","author":"S Fujii","year":"2007","unstructured":"Fujii S, Shimizu K, Hemmi H, Steinman RM (2007) Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity. Immunol Rev 220:183\u2013198","journal-title":"Immunol Rev"},{"key":"2459_CR117","doi-asserted-by":"crossref","first-page":"7775","DOI":"10.1158\/0008-5472.CAN-09-2123","volume":"69","author":"HG Kopp","year":"2009","unstructured":"Kopp HG, Placke T, Salih HR (2009) Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity. Cancer Res 69:7775\u20137783","journal-title":"Cancer Res"},{"key":"2459_CR118","doi-asserted-by":"crossref","first-page":"7287","DOI":"10.4049\/jimmunol.180.11.7287","volume":"180","author":"HJ van der Vliet","year":"2008","unstructured":"van der Vliet HJ, Wang R, Yue SC, Koon HB, Balk SP, Exley MA (2008) Circulating myeloid dendritic cells of advanced cancer patients result in reduced activation and a biased cytokine profile in invariant NKT cells. J Immunol 180:7287\u20137293","journal-title":"J Immunol"},{"key":"2459_CR119","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.748741","volume":"12","author":"EM Jarvis","year":"2021","unstructured":"Jarvis EM, Collings S, Authier-Hall A, Dasyam N, Luey B, Nacey J, Painter GF, Delahunt B, Hermans IF, Weinkove R (2021) Mucosal-associated invariant T (MAIT) cell dysfunction and PD-1 expression in prostate cancer: implications for immunotherapy. Front Immunol 12:748741","journal-title":"Front Immunol"},{"key":"2459_CR120","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1007\/s00262-021-02939-y","volume":"70","author":"W Rodin","year":"2021","unstructured":"Rodin W, Sundstr\u00f6m P, Ahlmanner F, Szeponik L, Zajt KK, Wettergren Y, Bexe Lindskog E, Quiding J\u00e4rbrink M (2021) Exhaustion in tumor-infiltrating Mucosal-Associated Invariant T (MAIT) cells from colon cancer patients. Cancer Immunol Immunother 70:3461\u20133475","journal-title":"Cancer Immunol Immunother"},{"key":"2459_CR121","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.4049\/jimmunol.1500258","volume":"195","author":"P Sundstr\u00f6m","year":"2015","unstructured":"Sundstr\u00f6m P, Ahlmanner F, Ak\u00e9us P, Sundquist M, Als\u00e9n S, Yrlid U, B\u00f6rjesson L, Sj\u00f6ling \u00c5, Gustavsson B, Wong SB, Quiding-J\u00e4rbrink M (2015) Human mucosa-associated invariant T cells accumulate in colon adenocarcinomas but produce reduced amounts of IFN-\u03b3. J Immunol 195:3472\u20133481","journal-title":"J Immunol"},{"key":"2459_CR122","volume":"13","author":"T Maekawa","year":"2018","unstructured":"Maekawa T, Osawa Y, Okada Y, Tachi N, Teramoto M, Kawamura T, Horiuchi T, Kato S, Kobayashi A, Kobayashi S, Sato K, Kimura F (2018) Low mucosal-associated invariant T-cell number in peripheral blood of patients with immune thrombocytopenia and their response to prednisolone. PLoS ONE 13:e0207149","journal-title":"PLoS ONE"},{"key":"2459_CR123","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2026.117251","volume":"187","author":"E \u00dcnal","year":"2026","unstructured":"\u00dcnal E, Azizo\u011flu ZB, \u00c7il M, \u00dczen R, Asaad NN, \u00c7alik \u015e, D\u00f6rteller K, T\u00fcrko\u011flu EM, Do\u011fan YE, Yilmaz E, \u00d6zcan A, Karak\u00fckc\u00fc M, Leblebisatan G, Eken A (2026) Eltrombopag-associated remodeling of the MAIT, MR1(+) and \u03b3\u03b4 T cells in pediatric immune thrombocytopenia. Int Immunopharmacol 187:117251","journal-title":"Int Immunopharmacol"},{"key":"2459_CR124","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/jth.13959","volume":"16","author":"L Servais","year":"2018","unstructured":"Servais L, W\u00e9ra O, Dibato Epoh J, Delierneux C, Bouznad N, Rahmouni S, Mazzucchelli G, Baiwir D, Delvenne P, Lancellotti P, Oury C (2018) Platelets contribute to the initiation of colitis-associated cancer by promoting immunosuppression. J Thromb Haemost 16:762\u2013777","journal-title":"J Thromb Haemost"},{"key":"2459_CR125","volume":"279","author":"H Xu","year":"2024","unstructured":"Xu H, Ma H, Li Y, Bi S, Cai K, Wu L, Zhang L, Guan H, Li C, Yang J, Qiu P (2024) Propylene glycol alginate sodium sulfate suppressed lung metastasis by blocking P-selectin to recruit CD4 regulatory T cells. Int J Biol Macromol 279:134976","journal-title":"Int J Biol Macromol"},{"key":"2459_CR126","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/s41586-025-08626-7","volume":"640","author":"J Yang","year":"2025","unstructured":"Yang J, Yamashita-Kanemaru Y, Morris BI, Contursi A, Trajkovski D, Xu J, Patrascan I, Benson J, Evans AC, Conti AG, Al-Deka A, Dahmani L, Avdic-Belltheus A, Zhang B, Okkenhaug H, Whiteside SK, Imianowski CJ, Wesolowski AJ, Webb LV, Puccio S, Tacconelli S, Bruno A, Di Berardino S, De Michele A, Welch HCE, Yu IS, Lin SW, Mitra S, Lugli E, van der Weyden L, Okkenhaug K, Saeb-Parsy K, Patrignani P, Adams DJ, Roychoudhuri R (2025) Aspirin prevents metastasis by limiting platelet TXA(2) suppression of T cell immunity. Nature 640:1052\u20131061","journal-title":"Nature"},{"key":"2459_CR127","doi-asserted-by":"crossref","first-page":"20240084","DOI":"10.1002\/EXP.20240084","volume":"5","author":"Q Lu","year":"2025","unstructured":"Lu Q, Ye H, Zhao J, Fan X, Wang K, Han Z, Liu T, Du L, Song J, Wang H, Zhang H, He Z, Sun J (2025) Surface-anchored ticagrelor gelatin nanoparticles-platelets system for enhanced anti-PD-L1 therapy response and boosted chemotherapeutic efficacy of nanomedicines. Exploration 5:20240084","journal-title":"Exploration"},{"key":"2459_CR128","doi-asserted-by":"crossref","first-page":"1696460","DOI":"10.3389\/fimmu.2025.1696460","volume":"16","author":"G Lupoli","year":"2025","unstructured":"Lupoli G, Bergamini S, Salsetta J, Mereu A, Cova A, D\u2019Angelo E, Shahaj E, Vergani E, Stroscia M, Di Carlo E, Rivoltini L, Verzoni E, Huber V (2025) Pazopanib-associated remodeling of platelet-immune cell crosstalk and immune suppressive platelet-derived extracellular vesicles in metastatic RCC. Front Immunol 16:1696460","journal-title":"Front Immunol"},{"key":"2459_CR129","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s40164-025-00676-x","volume":"14","author":"C Cai","year":"2025","unstructured":"Cai C, Liu Y, Lu R, Fan X, Zeng S, Gan P (2025) Platelets in cancer and immunotherapy: functional dynamics and therapeutic opportunities. Exp Hematol Oncol 14:83","journal-title":"Exp Hematol Oncol"},{"key":"2459_CR130","doi-asserted-by":"crossref","first-page":"27460","DOI":"10.18632\/oncotarget.25446","volume":"9","author":"V Rolfes","year":"2018","unstructured":"Rolfes V, Idel C, Pries R, Pl\u00f6tze-Martin K, Habermann J, Gemoll T, Bohnet S, Latz E, Ribbat-Idel J, Franklin BS, Wollenberg B (2018) PD-L1 is expressed on human platelets and is affected by immune checkpoint therapy. Oncotarget 9:27460\u201327470","journal-title":"Oncotarget"},{"key":"2459_CR131","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1084\/jem.20112741","volume":"209","author":"T Yokosuka","year":"2012","unstructured":"Yokosuka T, Takamatsu M, Kobayashi-Imanishi W, Hashimoto-Tane A, Azuma M, Saito T (2012) Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2. J Exp Med 209:1201\u20131217","journal-title":"J Exp Med"},{"key":"2459_CR132","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/s41423-022-00926-6","volume":"19","author":"J Chen","year":"2022","unstructured":"Chen J, Yang J, Wang W, Guo D, Zhang C, Wang S, Lu X, Huang X, Wang P, Zhang G, Zhang J, Wang J, Cai Z (2022) Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1. Cell Mol Immunol 19:1290\u20131301","journal-title":"Cell Mol Immunol"},{"key":"2459_CR133","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev-immunol-090222-110914","volume":"42","author":"A Baessler","year":"2024","unstructured":"Baessler A, Vignali DAA (2024) T cell exhaustion. Annu Rev Immunol 42:179\u2013206","journal-title":"Annu Rev Immunol"},{"key":"2459_CR134","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-025-01735-w","volume":"18","author":"Q Liu","year":"2025","unstructured":"Liu Q, Li J, Sun X, Lin J, Yu Z, Xiao Y, Li D, Sun B, Bao H, Liu Y (2025) Immunosenescence and cancer: molecular hallmarks, tumor microenvironment remodeling, and age-specific immunotherapy challenges. J Hematol Oncol 18:81","journal-title":"J Hematol Oncol"},{"key":"2459_CR135","volume":"15","author":"P Zhang","year":"2025","unstructured":"Zhang P, Zu R, Zhang X, Ren H, Rao L, Wang D, Li T, Leng P, Luo H (2025) Unveiling the \u201cdark matter\u201d of platelet involvement in tumor microenvironment. J Pharm Anal 15:101218","journal-title":"J Pharm Anal"},{"key":"2459_CR136","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/s41417-025-00915-7","volume":"32","author":"D Tang","year":"2025","unstructured":"Tang D, Kang R (2025) Platelet activation: a barrier to effective antitumor immunity. Cancer Gene Ther 32:741\u2013743","journal-title":"Cancer Gene Ther"},{"issue":"2025","key":"2459_CR137","volume":"6","author":"X Lei","year":"2020","unstructured":"Lei X, Zhang W, Zhang D (2020) Metabolic and epigenetic control of CD8(+) T cell exhaustion: the acetate-to-citrate switch. MedComm 6(2025):e70307","journal-title":"MedComm"},{"key":"2459_CR138","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41590-020-00834-9","volume":"22","author":"NE Scharping","year":"2021","unstructured":"Scharping NE, Rivadeneira DB, Menk AV, Vignali PDA, Ford BR, Rittenhouse NL, Peralta R, Wang Y, Wang Y, DePeaux K, Poholek AC, Delgoffe GM (2021) Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion. Nat Immunol 22:205\u2013215","journal-title":"Nat Immunol"},{"key":"2459_CR139","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s13402-025-01129-7","volume":"49","author":"A Nasir Kansestani","year":"2026","unstructured":"Nasir Kansestani A, Zare ME, Zhang J (2026) Platelets in the tumor microenvironment: potential mediators of immune exclusion and resistance to immune checkpoint inhibitor therapy. Cell Oncol 49:33","journal-title":"Cell Oncol"},{"key":"2459_CR140","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s42255-020-00280-9","volume":"2","author":"F Franco","year":"2020","unstructured":"Franco F, Jaccard A, Romero P, Yu YR, Ho PC (2020) Metabolic and epigenetic regulation of T-cell exhaustion. Nat Metab 2:1001\u20131012","journal-title":"Nat Metab"},{"key":"2459_CR141","doi-asserted-by":"publisher","DOI":"10.3390\/biom14070820","author":"HM Liu","year":"2024","unstructured":"Liu HM, Yu ZL, Xia HF, Zhang LZ, Fu QY, Wang Y, Gong HY, Chen G (2024) EGFR mutation and TKI treatment promote secretion of small extracellular vesicle PD-L1 and contribute to immunosuppression in NSCLC. Biomolecules. https:\/\/doi.org\/10.3390\/biom14070820","journal-title":"Biomolecules"},{"key":"2459_CR142","volume":"13","author":"R Fang","year":"2026","unstructured":"Fang R, Huang B, Li Y, Cai Z, Deng Y, Cen X, Sun W, Zhang J, Xu Z, Guo W, Lyu Y, Luo S, Chen Z, Lyu K, Wen W, Lei W (2026) PD-L1 on tumor-derived extracellular vesicles induces CD8(+) T cell terminal exhaustion and mediates anti-PD-1 resistance in head and neck squamous cell carcinoma. Adv Sci 13:e16348","journal-title":"Adv Sci"},{"key":"2459_CR143","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/s41423-023-01118-6","volume":"21","author":"Y Li","year":"2024","unstructured":"Li Y, Han M, Wei H, Huang W, Chen Z, Zhang T, Qian M, Jing L, Nan G, Sun X, Dai S, Wang K, Jiang J, Zhu P, Chen L (2024) Id2 epigenetically controls CD8(+) T-cell exhaustion by disrupting the assembly of the Tcf3-LSD1 complex. Cell Mol Immunol 21:292\u2013308","journal-title":"Cell Mol Immunol"},{"key":"2459_CR144","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1182\/blood-2013-03-492801","volume":"122","author":"B Laffont","year":"2013","unstructured":"Laffont B, Corduan A, Pl\u00e9 H, Duchez AC, Cloutier N, Boilard E, Provost P (2013) Activated platelets can deliver mRNA regulatory Ago2\u2022microRNA complexes to endothelial cells via microparticles. Blood 122:253\u2013261","journal-title":"Blood"},{"key":"2459_CR145","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1182\/blood.2019004119","volume":"137","author":"S Lazar","year":"2021","unstructured":"Lazar S, Goldfinger LE (2021) Platelets and extracellular vesicles and their cross talk with cancer. Blood 137:3192\u20133200","journal-title":"Blood"},{"key":"2459_CR146","volume":"28","author":"J Naghinezhad","year":"2026","unstructured":"Naghinezhad J, Kamali Yazdi E, Mohajerian A, Yousefi Chermehini N, Ghanavati P, Motamedi H, Rezaeeyan H (2026) The tumor-platelet-immune interface: driving metastasis, pre-metastatic niche formation and therapeutic vulnerabilities. Expert Rev Mol Med 28:e23","journal-title":"Expert Rev Mol Med"},{"key":"2459_CR147","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","volume":"176","author":"RS Apte","year":"2019","unstructured":"Apte RS, Chen DS, Ferrara N (2019) VEGF in signaling and disease: beyond discovery and development. Cell 176:1248\u20131264","journal-title":"Cell"},{"key":"2459_CR148","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cytogfr.2015.10.002","volume":"28","author":"E Borkham-Kamphorst","year":"2016","unstructured":"Borkham-Kamphorst E, Weiskirchen R (2016) The PDGF system and its antagonists in liver fibrosis. Cytokine Growth Factor Rev 28:53\u201361","journal-title":"Cytokine Growth Factor Rev"},{"key":"2459_CR149","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41423-023-00974-6","volume":"20","author":"S Cambier","year":"2023","unstructured":"Cambier S, Gouwy M, Proost P (2023) The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention. Cell Mol Immunol 20:217\u2013251","journal-title":"Cell Mol Immunol"},{"key":"2459_CR150","volume":"12","author":"BO Hwang","year":"2021","unstructured":"Hwang BO, Park SY, Cho ES, Zhang X, Lee SK, Ahn HJ, Chun KS, Chung WY, Song NY (2021) Platelet CLEC2-Podoplanin axis as a promising target for oral cancer treatment. Front Immunol 12:807600","journal-title":"Front Immunol"},{"key":"2459_CR151","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.693974","volume":"12","author":"JH Bourne","year":"2021","unstructured":"Bourne JH, Beristain-Covarrubias N, Zuidscherwoude M, Campos J, Di Y, Garlick E, Colicchia M, Terry LV, Thomas SG, Brill A, Bayry J, Watson SP, Rayes J (2021) CLEC-2 prevents accumulation and retention of inflammatory macrophages during murine peritonitis. Front Immunol 12:693974","journal-title":"Front Immunol"},{"key":"2459_CR152","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s13046-023-02900-0","volume":"42","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Yu Y, Zhang Z, Li D, Liang Z, Wang L, Chen Y, Liang Y, Niu H (2023) Cancer-associated fibroblasts-derived CXCL12 enhances immune escape of bladder cancer through inhibiting P62-mediated autophagic degradation of PDL1. J Exp Clin Cancer Res 42:316","journal-title":"J Exp Clin Cancer Res"},{"key":"2459_CR153","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.7150\/thno.68972","volume":"12","author":"Y Wu","year":"2022","unstructured":"Wu Y, Yi Z, Li J, Wei Y, Feng R, Liu J, Huang J, Chen Y, Wang X, Sun J, Yin X, Li Y, Wan J, Zhang L, Huang J, Du H, Wang X, Li Q, Ren G, Li H (2022) FGFR blockade boosts T cell infiltration into triple-negative breast cancer by regulating cancer-associated fibroblasts. Theranostics 12:4564\u20134580","journal-title":"Theranostics"},{"key":"2459_CR154","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1038\/s41467-022-29151-5","volume":"13","author":"J Li","year":"2022","unstructured":"Li J, Shu X, Xu J, Su SM, Chan UI, Mo L, Liu J, Zhang X, Adhav R, Chen Q, Wang Y, An T, Zhang X, Lyu X, Li X, Lei JH, Miao K, Sun H, Xing F, Zhang A, Deng C, Xu X (2022) S100A9-CXCL12 activation in BRCA1-mutant breast cancer promotes an immunosuppressive microenvironment associated with resistance to immunotherapy. Nat Commun 13:1481","journal-title":"Nat Commun"},{"key":"2459_CR155","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1158\/1078-0432.CCR-09-2329","volume":"16","author":"BA Teicher","year":"2010","unstructured":"Teicher BA, Fricker SP (2010) CXCL12 (SDF-1)\/CXCR4 pathway in cancer. Clin Cancer Res 16:2927\u20132931","journal-title":"Clin Cancer Res"},{"key":"2459_CR156","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.3389\/fimmu.2020.02149","volume":"11","author":"SC Silva-Cardoso","year":"2020","unstructured":"Silva-Cardoso SC, Tao W, Angiolilli C, Lopes AP, Bekker CPJ, Devaprasad A, Giovannone B, van Laar J, Cossu M, Marut W, Hack E, de Boer RJ, Boes M, Radstake T, Pandit A (2020) CXCL4 Links inflammation and fibrosis by reprogramming monocyte-derived dendritic cells in vitro. Front Immunol 11:2149","journal-title":"Front Immunol"},{"key":"2459_CR157","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4049\/jimmunol.1602020","volume":"199","author":"SC Silva-Cardoso","year":"2017","unstructured":"Silva-Cardoso SC, Affandi AJ, Spel L, Cossu M, van Roon JAG, Boes M, Radstake T (2017) CXCL4 exposure potentiates TLR-driven polarization of human monocyte-derived dendritic cells and increases stimulation of T cells. J Immunol 199:253\u2013262","journal-title":"J Immunol"},{"key":"2459_CR158","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.4049\/jimmunol.1900594","volume":"203","author":"BP Riesenberg","year":"2019","unstructured":"Riesenberg BP, Ansa-Addo EA, Gutierrez J, Timmers CD, Liu B, Li Z (2019) Cutting edge: targeting thrombocytes to rewire anticancer immunity in the tumor microenvironment and potentiate efficacy of PD-1 blockade. J Immunol 203:1105\u20131110","journal-title":"J Immunol"},{"key":"2459_CR159","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0021-9150(99)00241-5","volume":"148","author":"M Gawaz","year":"2000","unstructured":"Gawaz M, Brand K, Dickfeld T, Pogatsa-Murray G, Page S, Bogner C, Koch W, Sch\u00f6mig A, Neumann F (2000) Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis. Atherosclerosis 148:75\u201385","journal-title":"Atherosclerosis"},{"key":"2459_CR160","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26146567","author":"E Varela-L\u00f3pez","year":"2025","unstructured":"Varela-L\u00f3pez E, Pina-Canseco S, Mass\u00f3-Rojas F, Lerma C, Dom\u00ednguez AMM, \u00c1vila JOG, Torres-Narv\u00e1ez JC, Vargas-Gonz\u00e1lez A, P\u00e1ez-Arenas A (2025) Effect of platelet-derived microparticles on the expression of adhesion molecules in endothelial cells. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26146567","journal-title":"Int J Mol Sci"},{"key":"2459_CR161","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1006\/cyto.2001.0922","volume":"15","author":"KS Tudor","year":"2001","unstructured":"Tudor KS, Hess KL, Cook-Mills JM (2001) Cytokines modulate endothelial cell intracellular signal transduction required for VCAM-1-dependent lymphocyte transendothelial migration. Cytokine 15:196\u2013211","journal-title":"Cytokine"},{"key":"2459_CR162","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11427-015-4986-1","volume":"59","author":"S Zheng","year":"2016","unstructured":"Zheng S, Cao Y, Zhang W, Liu H, You J, Yin Y, Lou J, Li C (2016) Platelet-mediated adhesion facilitates leukocyte sequestration in hypoxia-reoxygenated microvessels. Sci China Life Sci 59:299\u2013311","journal-title":"Sci China Life Sci"},{"key":"2459_CR163","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003655","author":"MS Lutz","year":"2022","unstructured":"Lutz MS, Klimovich B, Maurer S, Heitmann JS, M\u00e4rklin M, Zekri L, Jung G, Salih HR, Hinterleitner C (2022) Platelets subvert antitumor efficacy of T cell-recruiting bispecific antibodies. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2021-003655","journal-title":"J Immunother Cancer"},{"key":"2459_CR164","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41392-021-00641-0","volume":"6","author":"F Wu","year":"2021","unstructured":"Wu F, Yang J, Liu J, Wang Y, Mu J, Zeng Q, Deng S, Zhou H (2021) Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer. Signal Transduct Target Ther 6:218","journal-title":"Signal Transduct Target Ther"},{"key":"2459_CR165","doi-asserted-by":"crossref","first-page":"20212","DOI":"10.1073\/pnas.1320318110","volume":"110","author":"C Feig","year":"2013","unstructured":"Feig C, Jones JO, Kraman M, Wells RJ, Deonarine A, Chan DS, Connell CM, Roberts EW, Zhao Q, Caballero OL, Teichmann SA, Janowitz T, Jodrell DI, Tuveson DA, Fearon DT (2013) Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer. Proc Natl Acad Sci USA 110:20212\u201320217","journal-title":"Proc Natl Acad Sci USA"},{"key":"2459_CR166","first-page":"783","volume":"5","author":"H Liu","year":"2013","unstructured":"Liu H, Wu Y, Wang Z, Yao Y, Chen F, Zhang H, Wang Y, Song Y (2013) Pretreatment platelet-to-lymphocyte ratio (PLR) as a predictor of response to first-line platinum-based chemotherapy and prognosis for patients with non-small cell lung cancer. J Thorac Dis 5:783\u2013789","journal-title":"J Thorac Dis"},{"key":"2459_CR167","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1159\/000492683","volume":"48","author":"Z Wang","year":"2018","unstructured":"Wang Z, Fang M, Li J, Yang R, Du J, Luo Y (2018) High platelet levels attenuate the efficacy of platinum-based treatment in non-small cell lung cancer. Cell Physiol Biochem 48:2456\u20132469","journal-title":"Cell Physiol Biochem"},{"key":"2459_CR168","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3892\/or.2016.4898","volume":"36","author":"S Ishikawa","year":"2016","unstructured":"Ishikawa S, Miyashita T, Inokuchi M, Hayashi H, Oyama K, Tajima H, Takamura H, Ninomiya I, Ahmed AK, Harman JW, Fushida S, Ohta T (2016) Platelets surrounding primary tumor cells are related to chemoresistance. Oncol Rep 36:787\u2013794","journal-title":"Oncol Rep"},{"key":"2459_CR169","first-page":"5216","volume":"58","author":"DE Hallahan","year":"1998","unstructured":"Hallahan DE, Staba-Hogan MJ, Virudachalam S, Kolchinsky A (1998) X-ray-induced P-selectin localization to the lumen of tumor blood vessels. Cancer Res 58:5216\u20135220","journal-title":"Cancer Res"},{"key":"2459_CR170","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.surg.2011.09.045","volume":"151","author":"A Mihaescu","year":"2012","unstructured":"Mihaescu A, Thornberg C, Sant\u00e9n S, Mattsson S, Jeppsson B, Thorlacius H (2012) Radiation-induced platelet-endothelial cell interactions are mediated by P-selectin and P-selectin glycoprotein ligand-1 in the colonic microcirculation. Surgery 151:606\u2013611","journal-title":"Surgery"},{"key":"2459_CR171","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol32080455","author":"S Peshin","year":"2025","unstructured":"Peshin S, Dharia A, Takrori E, Kaur J, Thanikachalam K, Iyer R (2025) Understanding chemotherapy-induced thrombocytopenia: implications for gastrointestinal cancer treatment. Curr Oncol. https:\/\/doi.org\/10.3390\/curroncol32080455","journal-title":"Curr Oncol"},{"key":"2459_CR172","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s13256-019-2245-y","volume":"13","author":"T Hasegawa","year":"2019","unstructured":"Hasegawa T, Ozaki Y, Inoue T, Watanabe Y, Fukuhara M, Yamaura T, Muto S, Okabe N, Higuchi M, Shio Y, Suzuki H (2019) Nivolumab-related severe thrombocytopenia in a patient with relapsed lung adenocarcinoma: a case report and review of the literature. J Med Case Rep 13:316","journal-title":"J Med Case Rep"},{"key":"2459_CR173","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1168120","volume":"13","author":"NR Neuendorff","year":"2023","unstructured":"Neuendorff NR, Boshikova B, Frankenstein L, Kirchner M, Rohde C, Goldschmidt H, Frey N, M\u00fcller-Tidow C, Jordan K, Sauer S, Janssen M (2023) Aspirin use and bleeding events during thrombocytopenia after autologous stem-cell transplantation for multiple myeloma. Front Oncol 13:1168120","journal-title":"Front Oncol"},{"key":"2459_CR174","doi-asserted-by":"crossref","first-page":"5777","DOI":"10.2147\/IJN.S316863","volume":"16","author":"Q Feng","year":"2021","unstructured":"Feng Q, Wang M, Muhtar E, Wang Y, Zhu H (2021) Nanoparticles of a new small-molecule P-selectin inhibitor attenuate thrombosis, inflammation, and tumor growth in two animal models. Int J Nanomedicine 16:5777\u20135795","journal-title":"Int J Nanomedicine"},{"key":"2459_CR175","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jconrel.2024.07.013","volume":"373","author":"A Safdar","year":"2024","unstructured":"Safdar A, Wang P, Muhaymin A, Nie G, Li S (2024) From bench to bedside: platelet biomimetic nanoparticles as a promising carriers for personalized drug delivery. J Control Release 373:128\u2013144","journal-title":"J Control Release"},{"key":"2459_CR176","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14235751","author":"S Marx","year":"2022","unstructured":"Marx S, Wilken F, Miebach L, Ispirjan M, Kinnen F, Paul S, Bien-M\u00f6ller S, Freund E, Baldauf J, Fleck S, Siebert N, Lode H, Stahl A, Rauch BH, Singer S, Ritter C, Schroeder HWS, Bekeschus S (2022) Immunophenotyping of circulating and intratumoral myeloid and T cells in glioblastoma patients. Cancers. https:\/\/doi.org\/10.3390\/cancers14235751","journal-title":"Cancers"},{"key":"2459_CR177","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.semcancer.2025.02.001","volume":"110","author":"Z Chen","year":"2025","unstructured":"Chen Z, Xu L, Yuan Y, Zhang S, Xue R (2025) Metabolic crosstalk between platelets and cancer: mechanisms, functions, and therapeutic potential. Semin Cancer Biol 110:65\u201382","journal-title":"Semin Cancer Biol"},{"key":"2459_CR178","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23909-z","author":"M Lacy","year":"2021","unstructured":"Lacy M, B\u00fcrger C, Shami A, Ahmadsei M, Winkels H, Nitz K, van Tiel CM, Seijkens TTP, Kusters PJH, Karshovka E, Prange KHM, Wu Y, Brouns SLN, Unterlugauer S, Kuijpers MJE, Reiche ME, Steffens S, Edsfeldt A, Megens RTA, Heemskerk JWM, Goncalves I, Weber C, Gerdes N, Atzler D, Lutgens E (2021) Cell-specific and divergent roles of the CD40L-CD40 axis in atherosclerotic vascular disease. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-021-23909-z","journal-title":"Nat Commun"},{"key":"2459_CR179","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/jso.27748","volume":"130","author":"RLD Santos","year":"2024","unstructured":"Santos RLD, Martins MR, Tavares VL, Neto JPD, Torres LC (2024) Analysis of the expression of cytokines and chemokines, platelet-leukocyte aggregates, sCD40L and sCD62P in cutaneous melanoma. J Surg Oncol 130:869\u2013881","journal-title":"J Surg Oncol"},{"key":"2459_CR180","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-022-04279-1","author":"Y Min","year":"2022","unstructured":"Min Y, Hao L, Liu X, Tan S, Song H, Ni H, Sheng Z, Jooss N, Liu X, Malmstr\u00f6m RE, Sun Y, Liu J, Tang H, Zhang H, Ma C, Peng J, Hou M, Li N (2022) Platelets fine-tune effector responses of na\u00efve CD4+ T cells via platelet factor 4-regulated transforming growth factor \u03b2 signaling. Cell Mol Life Sci. https:\/\/doi.org\/10.1007\/s00018-022-04279-1","journal-title":"Cell Mol Life Sci"},{"key":"2459_CR181","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/ijc.34281","volume":"152","author":"Y Peng","year":"2023","unstructured":"Peng Y, Tao Y, Zhang Y, Wang J, Yang J, Wang Y (2023) CD25: a potential tumor therapeutic target. Int J Cancer 152:1290\u20131303","journal-title":"Int J Cancer"},{"key":"2459_CR182","doi-asserted-by":"crossref","DOI":"10.1126\/science.adn8608","volume":"386","author":"A Kuratani","year":"2024","unstructured":"Kuratani A, Okamoto M, Kishida K, Okuzaki D, Sasai M, Sakaguchi S, Arase H, Yamamoto M (2024) Platelet factor 4-induced T(H)1-T(reg) polarization suppresses antitumor immunity. Science 386:eadn8608","journal-title":"Science"},{"key":"2459_CR183","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/s41586-025-08626-7","volume":"640","author":"J Yang","year":"2025","unstructured":"Yang J, Yamashita-Kanemaru Y, Morris BI, Contursi A, Trajkovski D, Xu J, Patrascan I, Benson J, Evans AC, Conti AG, Al-Deka A, Dahmani L, Avdic-Belltheus A, Zhang B, Okkenhaug H, Whiteside SK, Imianowski CJ, Wesolowski AJ, Webb LV, Puccio S, Tacconelli S, Bruno A, Di Berardino S, De Michele A, Welch HCE, Yu IS, Lin S-W, Mitra S, Lugli E, van der Weyden L, Okkenhaug K, Saeb-Parsy K, Patrignani P, Adams DJ, Roychoudhuri R (2025) Aspirin prevents metastasis by limiting platelet TXA2 suppression of T cell immunity. Nature 640:1052\u20131061","journal-title":"Nature"},{"key":"2459_CR184","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119279","author":"KA Pankowska","year":"2023","unstructured":"Pankowska KA, B\u0119dkowska GE, Chociej-Stypu\u0142kowska J, Rusak M, D\u0105browska M, Osada J (2023) Crosstalk of immune cells and platelets in an ovarian cancer microenvironment and their prognostic significance. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24119279","journal-title":"Int J Mol Sci"},{"key":"2459_CR185","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241511927","author":"R Anderson","year":"2023","unstructured":"Anderson R, Rapoport BL, Steel HC, Theron AJ (2023) Pro-tumorigenic and thrombotic activities of platelets in lung cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241511927","journal-title":"Int J Mol Sci"},{"key":"2459_CR186","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-002068","author":"D Melisi","year":"2021","unstructured":"Melisi D, Oh DY, Hollebecque A, Calvo E, Varghese A, Borazanci E, Macarulla T, Merz V, Zecchetto C, Zhao Y, Gueorguieva I, Man M, Gandhi L, Estrem ST, Benhadji KA, Lanasa MC, Avsar E, Guba SC, Garcia-Carbonero R (2021) Safety and activity of the TGF\u03b2 receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2020-002068","journal-title":"J Immunother Cancer"},{"key":"2459_CR187","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan5488","author":"Y Lan","year":"2018","unstructured":"Lan Y, Zhang D, Xu C, Hance KW, Marelli B, Qi J, Yu H, Qin G, Sircar A, Hern\u00e1ndez VM, Jenkins MH, Fontana RE, Deshpande A, Locke G, Sabzevari H, Radvanyi L, Lo KM (2018) Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-\u03b2. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aan5488","journal-title":"Sci Transl Med"},{"key":"2459_CR188","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.838079","author":"P Ballerini","year":"2022","unstructured":"Ballerini P, Contursi A, Bruno A, Mucci M, Tacconelli S, Patrignani P (2022) Inflammation and cancer: from the development of personalized indicators to novel therapeutic strategies. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.838079","journal-title":"Front Pharmacol"},{"key":"2459_CR189","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41586-024-08257-4","volume":"637","author":"A Elewaut","year":"2024","unstructured":"Elewaut A, Estivill G, Bayerl F, Castillon L, Novatchkova M, Pottendorfer E, Hoffmann-Haas L, Sch\u00f6nlein M, Nguyen TV, Lauss M, Andreatta F, Vulin M, Krecioch I, Bayerl J, Pedde A-M, Fabre N, Holstein F, Cronin SM, Rieser S, Laniti DD, Barras D, Coukos G, Quek C, Bai X, Mu\u00f1oz i Ordo\u00f1o M, Wiesner T, Zuber J, J\u00f6nsson G, B\u00f6ttcher JP, Vanharanta S, Obenauf AC (2024) Cancer cells impair monocyte-mediated T cell stimulation to evade immunity. Nature 637:716\u2013725","journal-title":"Nature"},{"issue":"21","key":"2459_CR190","doi-asserted-by":"crossref","first-page":"e178644","DOI":"10.1172\/jci.insight.178644","volume":"9","author":"N Markosyan","year":"2024","unstructured":"Markosyan N, Kim IK, Arora C, Quinones-Ware L, Joshi N, Cheng N, Schechter EY, Tobias JW, Hochberg JE, Corse E, Liu K (2024) Pivotal roles for cancer cell\u2013intrinsic mPGES-1 and autocrine EP4 signaling in suppressing antitumor immunity. JCI Insight 9(21):e178644","journal-title":"JCI Insight"},{"key":"2459_CR191","volume":"586","author":"K Wang","year":"2024","unstructured":"Wang K, Wu J, Yang Z, Zheng B, Shen S, Wang RR, Zhang Y, Wang HY, Chen L, Qiu X (2024) Hyperactivation of \u03b2-catenin signal in hepatocellular carcinoma recruits myeloid-derived suppressor cells through PF4-CXCR3 axis. Cancer Lett 586:216690","journal-title":"Cancer Lett"},{"key":"2459_CR192","doi-asserted-by":"crossref","first-page":"7077","DOI":"10.1038\/s41467-024-51096-0","volume":"15","author":"C Zhang","year":"2024","unstructured":"Zhang C, Li K, Zhu H, Cheng M, Chen S, Ling R, Wang C, Chen D (2024) ITGB6 modulates resistance to anti-CD276 therapy in head and neck cancer by promoting PF4(+) macrophage infiltration. Nat Commun 15:7077","journal-title":"Nat Commun"},{"key":"2459_CR193","doi-asserted-by":"crossref","unstructured":"L. Li, M.W. Shirkey, T. Zhang, W. Piao, X. Li, J. Zhao, Z. Mei, Y. Guo, V. Saxena, A. Kensiski, S. J. Gavzy, Y. Song, B. Ma, J. Wu, Y. Xiong, L. Wu, X. Fan, H. Roussey, M. Li, A. S. Krupnick, R. Abdi, J. S. Bromberg (2022) Lymph node fibroblastic reticular cells preserve a tolerogenic niche in allograft transplantation through laminin \u03b14. J Clin Investig 132","DOI":"10.1172\/JCI156994"},{"key":"2459_CR194","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.trecan.2025.04.014","volume":"11","author":"P Berraondo","year":"2025","unstructured":"Berraondo P, Cuesta R, Aranda F, Martinez-Ria\u00f1o A, Eguren-Santamaria I, Luri-Rey C, Risson A, Melero A, Gomis G, Melero I (2025) Immunocytokines and cytokine neutralization for cancer immunotherapy. Trends Cancer 11:790\u2013805","journal-title":"Trends Cancer"},{"key":"2459_CR195","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/imr.13119","volume":"312","author":"E Boilard","year":"2022","unstructured":"Boilard E, Bellio M (2022) Platelet extracellular vesicles and the secretory interactome join forces in health and disease. Immunol Rev 312:38\u201351","journal-title":"Immunol Rev"},{"key":"2459_CR196","doi-asserted-by":"crossref","first-page":"115709","DOI":"10.1016\/j.biopha.2023.115709","volume":"168","author":"C Colarusso","year":"2023","unstructured":"Colarusso C, Falanga A, Terlizzi M, De Rosa I, Somma P, Sommella EM, Caponigro V, Panico L, Salviati E, Campiglia P, Salatiello G, Tramontano T, Maiolino P, Pinto A, Sorrentino R (2023) High levels of PD-L1 on platelets of NSCLC patients contributes to the pharmacological activity of Atezolizumab. Biomed Pharmacother 168:115709","journal-title":"Biomed Pharmacother"},{"key":"2459_CR197","volume":"14","author":"H Li","year":"2023","unstructured":"Li H, Zhang L, Yang F, Zhao R, Li X, Li H (2023) Impact of concomitant medications on the efficacy of immune checkpoint inhibitors: an umbrella review. Front Immunol 14:1218386","journal-title":"Front Immunol"},{"key":"2459_CR198","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10555-017-9675-z","volume":"36","author":"A Ornelas","year":"2017","unstructured":"Ornelas A, Zacharias-Millward N, Menter DG, Davis JS, Lichtenberger L, Hawke D, Hawk E, Vilar E, Bhattacharya P, Millward S (2017) Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention. Cancer Metastasis Rev 36:289\u2013303","journal-title":"Cancer Metastasis Rev"},{"key":"2459_CR199","first-page":"1","volume":"2022","author":"X Xiao","year":"2022","unstructured":"Xiao X, Zeng S, Li Y, Li L, Zhang J, Chen S (2022) Aspirin Suppressed PD-L1 Expression through Suppressing KAT5 and Subsequently Inhibited PD-1 and PD-L1 Signaling to Attenuate OC Development. J Oncol 2022:1\u201313","journal-title":"J Oncol"},{"key":"2459_CR200","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.jcin.2019.03.034","volume":"12","author":"D Sibbing","year":"2019","unstructured":"Sibbing D, Aradi D, Alexopoulos D, Ten Berg J, Bhatt DL, Bonello L, Collet JP, Cuisset T, Franchi F, Gross L, Gurbel P, Jeong YH, Mehran R, Moliterno DJ, Neumann FJ, Pereira NL, Price MJ, Sabatine MS, So DYF, Stone GW, Storey RF, Tantry U, Trenk D, Valgimigli M, Waksman R, Angiolillo DJ (2019) Updated expert consensus statement on platelet function and genetic testing for guiding P2Y(12) receptor inhibitor treatment in percutaneous coronary intervention. JACC Cardiovasc Interv 12:1521\u20131537","journal-title":"JACC Cardiovasc Interv"},{"key":"2459_CR201","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.704945","author":"AL Palacios-Acedo","year":"2021","unstructured":"Palacios-Acedo AL, Mezouar S, M\u00e8ge D, Crescence L, Dubois C, Panicot-Dubois L (2021) P2RY12-inhibitors reduce cancer-associated thrombosis and tumor growth in pancreatic cancers. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2021.704945","journal-title":"Front Oncol"},{"key":"2459_CR202","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1111\/jth.15478","volume":"19","author":"A Asgari","year":"2021","unstructured":"Asgari A, Lesyk G, Poitras E, Govindasamy N, Terry K, To R, Back V, Rudzinski JK, Lewis JD, Jurasz P (2021) Platelets stimulate programmed death-ligand 1 expression by cancer cells: inhibition by anti-platelet drugs. J Thromb Haemost JTH 19:2862\u20132872","journal-title":"J Thromb Haemost JTH"},{"key":"2459_CR203","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14246146","author":"H Kadota","year":"2022","unstructured":"Kadota H, Yuge R, Shimizu D, Miyamoto R, Otani R, Hiyama Y, Takigawa H, Hayashi R, Urabe Y, Kitadai Y, Oka S, Tanaka S (2022) Anti-programmed cell death-1 antibody and dasatinib combination therapy exhibits efficacy in metastatic colorectal cancer mouse models. Cancers. https:\/\/doi.org\/10.3390\/cancers14246146","journal-title":"Cancers"},{"key":"2459_CR204","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155772","volume":"150","author":"AS Razavi","year":"2022","unstructured":"Razavi AS, Mohtashami M, Razi S, Rezaei N (2022) TGF-\u03b2 signaling and the interaction between platelets and T-cells in tumor microenvironment: foes or friends? Cytokine 150:155772","journal-title":"Cytokine"},{"key":"2459_CR205","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110648","volume":"122","author":"Z Karami","year":"2023","unstructured":"Karami Z, Mortezaee K, Majidpoor J (2023) Dual anti-PD-(L)1\/TGF-\u03b2 inhibitors in cancer immunotherapy: updated. Int Immunopharmacol 122:110648","journal-title":"Int Immunopharmacol"},{"key":"2459_CR206","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","volume":"168","author":"P Sharma","year":"2017","unstructured":"Sharma P, Hu-Lieskovan S, Wargo JA, Ribas A (2017) Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell 168:707\u2013723","journal-title":"Cell"},{"key":"2459_CR207","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/cpt.2485","volume":"111","author":"A Tosetto","year":"2021","unstructured":"Tosetto A, Rocca B, Petrucci G, Betti S, Soldati D, Rossi E, Timillero A, Cavalca V, Porro B, Iurlo A, Cattaneo D, Bucelli C, Dragani A, Di Ianni M, Ranalli P, Palandri F, Vianelli N, Beggiato E, Lanzarone G, Ruggeri M, Carli G, Elli EM, Priolo S, Randi ML, Bertozzi I, Loscocco GG, Ricco A, Specchia G, Vannucchi AM, Rodeghiero F, De Stefano V, Patrono C (2021) Association of platelet thromboxane inhibition by low-dose aspirin with platelet count and cytoreductive therapy in essential thrombocythemia. Clin Pharmacol Ther 111:939\u2013949","journal-title":"Clin Pharmacol Ther"},{"key":"2459_CR208","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119612","volume":"277","author":"N Pavlovi\u0107","year":"2021","unstructured":"Pavlovi\u0107 N, Kopsida M, Gerwins P, Heindryckx F (2021) Activated platelets contribute to the progression of hepatocellular carcinoma by altering the tumor environment. Life Sci 277:119612","journal-title":"Life Sci"},{"key":"2459_CR209","doi-asserted-by":"crossref","first-page":"5668","DOI":"10.1182\/bloodadvances.2021006120","volume":"6","author":"Q Guo","year":"2022","unstructured":"Guo Q, Malloy MW, Roweth HG, McAllister SS, Italiano JE, Battinelli EM (2022) Platelets upregulate tumor cell programmed death ligand 1 in an epidermal growth factor receptor-dependent manner in vitro. Blood Adv 6:5668\u20135675","journal-title":"Blood Adv"},{"key":"2459_CR210","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16203533","author":"ZR Isingizwe","year":"2024","unstructured":"Isingizwe ZR, Sjoelund V, Benbrook DM (2024) Implications of GPIIB-IIIA integrin and liver X receptor in platelet-induced compression of ovarian cancer multi-cellular spheroids. Cancers. https:\/\/doi.org\/10.3390\/cancers16203533","journal-title":"Cancers"},{"key":"2459_CR211","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12006-1","author":"X Da","year":"2024","unstructured":"Da X, Cao B, Mo J, Xiang Y, Hu H, Qiu C, Zhang C, Lv B, Zhang H, He C, Yang Y (2024) Inhibition of growth of hepatocellular carcinoma by co-delivery of anti-PD-1 antibody and sorafenib using biomimetic nano-platelets. BMC Cancer. https:\/\/doi.org\/10.1186\/s12885-024-12006-1","journal-title":"BMC Cancer"},{"key":"2459_CR212","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202103600","author":"Y Liu","year":"2021","unstructured":"Liu Y, Sukumar UK, Kanada M, Krishnan A, Massoud TF, Paulmurugan R (2021) Camouflaged hybrid cancer cell\u2010platelet fusion membrane nanovesicles deliver therapeutic microRNAs to presensitize triple\u2010negative breast cancer to doxorubicin. Adv Funct Mater. https:\/\/doi.org\/10.1002\/adfm.202103600","journal-title":"Adv Funct Mater"},{"key":"2459_CR213","doi-asserted-by":"publisher","DOI":"10.1111\/cas.70167","author":"T Nakayama","year":"2025","unstructured":"Nakayama T, Shoda K, Higuchi Y, Ozawa T, Tanaka H, Saito R, Maruyama S, Takiguchi K, Izumo W, Furuya S, Shiraishi K, Kawaguchi Y, Amemiya H, Kawaida H, Yoshimura K, Tsukiji N, Suzuki-Inoue K, Ichikawa D (2025) Potential of platelet-based drug delivery system for treating peritoneal metastasis of gastric cancer. Cancer Sci. https:\/\/doi.org\/10.1111\/cas.70167","journal-title":"Cancer Sci"},{"key":"2459_CR214","volume":"122","author":"Y Wang","year":"2025","unstructured":"Wang Y, Ogunnaike E, Yang H, Yuan S, Hong R, Barrett A, Ebong E, Liu B, Dotti G, Hu Q (2025) Platelet-engineered CAR-T cells as adjuvant therapy after cancer surgery. Proc Natl Acad Sci USA 122:e2522020122","journal-title":"Proc Natl Acad Sci USA"},{"key":"2459_CR215","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jtha.2023.10.028","volume":"22","author":"JR Shaw","year":"2024","unstructured":"Shaw JR, Li N, Abdulrehman J, Stella SF, St John M, Nixon J, Spyropoulos AC, Schulman S, Wang TF, Carrier M, Douketis JD (2024) Periprocedural management of direct oral anticoagulants in patients with atrial fibrillation and active cancer. J Thromb Haemost 22:727\u2013737","journal-title":"J Thromb Haemost"},{"key":"2459_CR216","doi-asserted-by":"publisher","DOI":"10.3390\/ph15050557","author":"B Fattizzo","year":"2022","unstructured":"Fattizzo B, Rampi N, Barcellini W (2022) Hematological and extra-hematological autoimmune complications after checkpoint inhibitors. Pharmaceuticals. https:\/\/doi.org\/10.3390\/ph15050557","journal-title":"Pharmaceuticals"},{"key":"2459_CR217","volume":"14","author":"H Yang","year":"2023","unstructured":"Yang H, Liu Z, Li R, Huang R, Peng X (2023) The association between aspirin use and immune-related adverse events in specific cancer patients receiving ICIs therapy: analysis of the FAERS database. Front Pharmacol 14:1259628","journal-title":"Front Pharmacol"},{"key":"2459_CR218","first-page":"e70399","volume":"8","author":"M Saiki","year":"2025","unstructured":"Saiki M, Takusagawa K, Takahashi N, Homma K, Satoh T, Furuya S, Shimamura S, Omori C, Ohkoshi H, Hoshino Y, Uchida Y, Ikemura S, Soejima K (2025) Effect of the combination of concomitant drugs on efficacy of immune checkpoint inhibitors in non-small cell lung cancer. Cancer Rep 8:e70399","journal-title":"Cancer Rep"},{"issue":"1","key":"2459_CR219","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41392-025-02198-8","volume":"10","author":"Y Tian","year":"2025","unstructured":"Tian Y, Zong Y, Pang Y, Zheng Z, Ma Y, Zhang C, Gao J (2025) Platelets and diseases: signal transduction and advances in targeted therapy. Signal Transduct Target Ther 10(1):159","journal-title":"Signal Transduct Target Ther"},{"key":"2459_CR220","volume":"28","author":"J Naghinezhad","year":"2026","unstructured":"Naghinezhad J, Mohajerian A, Ahadi S, Khodakarim N, Hamblin MR, Rezaeeyan H (2026) When GPVI goes rogue: pathogenesis and therapeutic horizons in ITP. Expert Rev Mol Med 28:e20","journal-title":"Expert Rev Mol Med"},{"key":"2459_CR221","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-023-01530-x","author":"J-G Zhao","year":"2023","unstructured":"Zhao J-G, Li Y-J, Wu Y, Zhang K, Peng L-J, Chen H (2023) Revealing platelet-related subtypes and prognostic signature in pancreatic adenocarcinoma. BMC Med Genomics. https:\/\/doi.org\/10.1186\/s12920-023-01530-x","journal-title":"BMC Med Genomics"},{"key":"2459_CR222","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030730","author":"A-L Palacios-Acedo","year":"2022","unstructured":"Palacios-Acedo A-L, Langiu M, Crescence L, M\u00e8ge D, Dubois C, Panicot-Dubois L (2022) Platelet and cancer-cell interactions modulate cancer-associated thrombosis risk in different cancer types. Cancers. https:\/\/doi.org\/10.3390\/cancers14030730","journal-title":"Cancers"},{"key":"2459_CR223","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.965033","author":"M Yuan","year":"2022","unstructured":"Yuan M, Jia Y, Xing Y, Wang Y, Liu Y, Liu X, Liu D (2022) Screening and validation of platelet activation-related lncRNAs as potential biomarkers for prognosis and immunotherapy in gastric cancer patients. Front Genet. https:\/\/doi.org\/10.3389\/fgene.2022.965033","journal-title":"Front Genet"},{"key":"2459_CR224","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00855-2","author":"Q-J Gai","year":"2022","unstructured":"Gai Q-J, Fu Z, He J, Mao M, Yao X-X, Qin Y, Lan X, Zhang L, Miao J-Y, Wang Y-X, Zhu J, Yang F-C, Lu H-M, Yan Z-X, Chen F-L, Shi Y, Ping Y-F, Cui Y-H, Zhang X, Liu X, Yao X-H, Lv S-Q, Bian X-W, Wang Y (2022) EPHA2 mediates PDGFA activity and functions together with PDGFRA as prognostic marker and therapeutic target in glioblastoma. Signal Transduct Target Ther. https:\/\/doi.org\/10.1038\/s41392-021-00855-2","journal-title":"Signal Transduct Target Ther"},{"key":"2459_CR225","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1402217","author":"J Fu","year":"2024","unstructured":"Fu J, Yue X, Zou Y, Zhang J, Wang X, Zhang D (2024) Association of hemoglobin, albumin, lymphocyte, and platelet score with risk of all-cause and cause-specific mortality among cancer survivors: NHANES 1999-2018. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2024.1402217","journal-title":"Front Oncol"},{"key":"2459_CR226","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1038\/s41591-024-03215-z","volume":"30","author":"J Klughammer","year":"2024","unstructured":"Klughammer J, Abravanel DL, Segerstolpe \u00c5, Blosser TR, Goltsev Y, Cui Y, Goodwin DR, Sinha A, Ashenberg O, Slyper M, Vigneau S, Jan\u00e9\u2010Valbuena J, Alon S, Caraccio C, Chen J, Cohen O, Cullen N, DelloStritto LK, Dionne D, Files J, Frangieh A, Helvie K, Hughes ME, Inga S, Kanodia A, Lako A, MacKichan C, Mages S, Moriel N, Murray E, Napolitano S, Nguyen K, Nitzan M, Ortiz R, Patel M, Pfaff KL, Porter CBM, Rotem A, Strauss S, Strasser R, Thorner AR, Turner M, Wakiro I, Waldman J, Wu J, G\u00f3mez Tejeda Za\u00f1udo J, Zhang D, Lin NU, Tolaney SM, Winer EP, Boyden ES, Chen F, Nolan GP, Rodig SJ, Zhuang X, Rozenblatt-Rosen O, Johnson BE, Regev A, Wagle N (2024) A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological features. Nat Med 30:3236\u20133249","journal-title":"Nat Med"},{"key":"2459_CR227","first-page":"533","volume":"31","author":"D Kashyap","year":"2023","unstructured":"Kashyap D, Bal A, Irinike S, Khare S, Bhattacharya S, Das A, Singh G (2023) Heterogeneity of the tumor microenvironment across molecular subtypes of breast cancer. Appl Immunohistochem Mol Morphol AIMM 31:533\u2013543","journal-title":"Appl Immunohistochem Mol Morphol AIMM"},{"issue":"1","key":"2459_CR228","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13059-022-02677-z","volume":"23","author":"AM Khaliq","year":"2022","unstructured":"Khaliq AM, Erdogan C, Kurt Z, Turgut SS, Grunvald MW, Rand T, Khare S, Borgia JA, Hayden DM, Pappas SG, Govekar HR, Kam AE, Reiser J, Turaga K, Radovich M, Zang Y, Qiu Y, Liu Y, Fishel ML, Turk A, Gupta V, Al-Sabti R, Subramanian J, Kuzel TM, Sadanandam A, Waldron L, Hussain A, Saleem M, El-Rayes B, Salahudeen AA, Masood A (2022) Refining colorectal cancer classification and clinical stratification through a single-cell atlas. Genome Biol 23(1):113","journal-title":"Genome Biol"},{"issue":"1","key":"2459_CR229","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12964-025-02034-0","volume":"23","author":"J Li","year":"2025","unstructured":"Li J, Liu J, Yang S, Xia Y, Meng Q, Sun B, Liu Y, Zhao B, Jin J, Xu H, Wang L, Zhang P, Cheng Z (2025) PD-L1 positive platelets mediate resistance to immune checkpoint inhibitors in patients with colorectal cancer. Cell Commun Signal 23(1):29","journal-title":"Cell Commun Signal"},{"key":"2459_CR230","doi-asserted-by":"crossref","first-page":"1259628","DOI":"10.3389\/fphar.2023.1259628","volume":"14","author":"H Yang","year":"2023","unstructured":"Yang H, Liu Z, Li R, Huang R, Peng X (2023) The association between aspirin use and immune-related adverse events in specific cancer patients receiving ICIs therapy: analysis of the FAERS database. Front Pharmacol 14:1259628","journal-title":"Front Pharmacol"},{"issue":"1","key":"2459_CR231","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s44276-024-00057-7","volume":"2","author":"Z Quandt","year":"2024","unstructured":"Quandt Z, Jacob S, Fadlullah MZH, Wu C, Wu C, Huppert L, Levine LS, Sison P, Tsai KK, Chow M, Kang JH, Hwang J, Lee JC, Oglesby A, Venegas J, Brintz BJ, Tan AC, Anderson MS, Rosenblum MD, Young A, Daud AI (2024) Phase II trial of pembrolizumab, ipilimumab, and aspirin in melanoma: clinical outcomes and translational predictors of response. BJC Rep 2(1):46","journal-title":"BJC Rep"},{"key":"2459_CR232","doi-asserted-by":"crossref","unstructured":"B. E. St\u00e4hli, C. Gebhard, V. Duchatelle, D. Cournoyer, T. Petroni, J. F. Tanguay, S. Robb, J. Mann, M. C. Guertin, R. S. Wright, P. L. L'Allier, J. C. Tardif (2016) Effects of the P\u2010selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention according to timing of infusion: insights from the SELECT\u2010ACS trial. J American Heart Assoc 5","DOI":"10.1161\/JAHA.116.004255"},{"key":"2459_CR233","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-002084","author":"C Egelston","year":"2021","unstructured":"Egelston C, Guo W, Yost S, Lee JS, Rose D, Avalos C, Ye J, Frankel P, Schmolze D, Waisman J, Lee P, Yuan Y (2021) Pre-existing effector T-cell levels and augmented myeloid cell composition denote response to CDK4\/6 inhibitor palbociclib and pembrolizumab in hormone receptor-positive metastatic breast cancer. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2020-002084","journal-title":"J Immunother Cancer"},{"key":"2459_CR234","volume":"13","author":"MA Schneider","year":"2021","unstructured":"Schneider MA, Heeb L, Beffinger MM, Pantelyushin S, Linecker M, Roth L, Lehmann K, Ungeth\u00fcm U, Kobold S, Graf R, van den Broek M, Vom Berg J, Gupta A, Clavien PA (2021) Attenuation of peripheral serotonin inhibits tumor growth and enhances immune checkpoint blockade therapy in murine tumor models. Sci Transl Med 13:eabc8188","journal-title":"Sci Transl Med"},{"key":"2459_CR235","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aam7729","author":"A Prestipino","year":"2018","unstructured":"Prestipino A, Emhardt AJ, Aumann K, O\u2019Sullivan D, Gorantla SP, Duquesne S, Melchinger W, Braun L, Vuckovic S, Boerries M, Busch H, Halbach S, Pennisi S, Poggio T, Apostolova P, Veratti P, Hettich M, Niedermann G, Bartholom\u00e4 M, Shoumariyeh K, Jutzi JS, Wehrle J, Dierks C, Becker H, Schmitt-Graeff A, Follo M, Pfeifer D, Rohr J, Fuchs S, Ehl S, Hartl FA, Minguet S, Miething C, Heidel FH, Kr\u00f6ger N, Triviai I, Brummer T, Finke J, Illert AL, Ruggiero E, Bonini C, Duyster J, Pahl HL, Lane SW, Hill GR, Blazar BR, von Bubnoff N, Pearce EL, Zeiser R (2018) Oncogenic JAK2 V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aam7729","journal-title":"Sci Transl Med"},{"key":"2459_CR236","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jtha.2024.12.016","volume":"23","author":"EC Josefsson","year":"2025","unstructured":"Josefsson EC (2025) Platelets and megakaryocytes in cancer. J Thromb Haemost 23:804\u2013816","journal-title":"J Thromb Haemost"},{"key":"2459_CR237","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005433","author":"A Li","year":"2022","unstructured":"Li A, Chang Y, Song NJ, Wu X, Chung D, Riesenberg BP, Velegraki M, Giuliani GD, Das K, Okimoto T, Kwon H, Chakravarthy KB, Bolyard C, Wang Y, He K, Gatti-Mays M, Das J, Yang Y, Gewirth DT, Ma Q, Carbone D, Li Z (2022) Selective targeting of GARP-LTGF\u03b2 axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8(+) T cell antitumor immunity. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2022-005433","journal-title":"J Immunother Cancer"},{"key":"2459_CR238","volume":"130","author":"J Guo","year":"2024","unstructured":"Guo J, Niu Z, Lv R, Yuan J, Zhang Z, Guan X, Li D, Zhang H, Zhao A, Feng J, Liu D, Zhou X, Gong J (2024) A novel GARP humanized mouse model for efficacy assessment of GARP-targeting therapies. Int Immunopharmacol 130:111782","journal-title":"Int Immunopharmacol"},{"key":"2459_CR239","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.stem.2024.06.003","volume":"31","author":"PE Saw","year":"2024","unstructured":"Saw PE, Liu Q, Wong PP, Song E (2024) Cancer stem cell mimicry for immune evasion and therapeutic resistance. Cell Stem Cell 31:1101\u20131112","journal-title":"Cell Stem Cell"},{"key":"2459_CR240","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12943-024-01990-4","volume":"23","author":"M Kundu","year":"2024","unstructured":"Kundu M, Butti R, Panda VK, Malhotra D, Das S, Mitra T, Kapse P, Gosavi SW, Kundu GC (2024) Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer. Mol Cancer 23:92","journal-title":"Mol Cancer"},{"key":"2459_CR241","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","volume":"19","author":"A Chow","year":"2022","unstructured":"Chow A, Perica K, Klebanoff CA, Wolchok JD (2022) Clinical implications of T cell exhaustion for cancer immunotherapy. Nat Rev Clin Oncol 19:775\u2013790","journal-title":"Nat Rev Clin Oncol"},{"key":"2459_CR242","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41577-021-00574-3","volume":"22","author":"M Philip","year":"2021","unstructured":"Philip M, Schietinger A (2021) CD8+ T cell differentiation and dysfunction in cancer. Nat Rev Immunol 22:209\u2013223","journal-title":"Nat Rev Immunol"},{"key":"2459_CR243","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-025-03877-w","author":"J Gan","year":"2025","unstructured":"Gan J, Zhang X, Guo J (2025) The role of platelets in tumor immune evasion and metastasis: mechanisms and therapeutic implications. Cancer Cell Int. https:\/\/doi.org\/10.1186\/s12935-025-03877-w","journal-title":"Cancer Cell Int"},{"key":"2459_CR244","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aai7911","author":"S Rachidi","year":"2017","unstructured":"Rachidi S, Metelli A, Riesenberg B, Wu BX, Nelson MH, Wallace C, Paulos CM, Rubinstein MP, Garrett-Mayer E, Hennig M, Bearden DW, Yang Y, Liu B, Li Z (2017) Platelets subvert T cell immunity against cancer via GARP-TGF\u03b2 axis. Sci Immunol. https:\/\/doi.org\/10.1126\/sciimmunol.aai7911","journal-title":"Sci Immunol"},{"key":"2459_CR245","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13092053","author":"CM Neophytou","year":"2021","unstructured":"Neophytou CM, Panagi M, Stylianopoulos T, Papageorgis P (2021) The role of tumor microenvironment in cancer metastasis: molecular mechanisms and therapeutic opportunities. Cancers. https:\/\/doi.org\/10.3390\/cancers13092053","journal-title":"Cancers"},{"key":"2459_CR246","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14081947","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Manouchehri Doulabi E, Herre M, Cedervall J, Qiao Q, Miao Z, Hamidi A, Hellman L, Kamali-Moghaddam M, Olsson A-K (2022) Platelet-derived PDGFB promotes recruitment of cancer-associated fibroblasts, deposition of extracellular matrix and Tgf\u03b2 signaling in the tumor microenvironment. Cancers. https:\/\/doi.org\/10.3390\/cancers14081947","journal-title":"Cancers"},{"key":"2459_CR247","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2174\/1567201820666230712103942","volume":"21","author":"P Fu","year":"2024","unstructured":"Fu P, Yin S, Cheng H, Xu W, Jiang J (2024) Engineered exosomes for drug delivery in cancer therapy: a promising approach and application. Curr Drug Deliv 21:817\u2013827","journal-title":"Curr Drug Deliv"},{"key":"2459_CR248","doi-asserted-by":"publisher","DOI":"10.3390\/cells14100748","author":"A Fernandez","year":"2025","unstructured":"Fernandez A, Artola M, Leon S, Otegui N, Jimeno A, Serrano D, Calvo A (2025) Cancer vulnerabilities through targeting the ATR\/Chk1 and ATM\/Chk2 axes in the context of DNA damage. Cells. https:\/\/doi.org\/10.3390\/cells14100748","journal-title":"Cells"},{"key":"2459_CR249","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1021\/acs.accounts.0c00339","volume":"53","author":"X Han","year":"2020","unstructured":"Han X, Li H, Zhou D, Chen Z, Gu Z (2020) Local and targeted delivery of immune checkpoint blockade therapeutics. Acc Chem Res 53:2521\u20132533","journal-title":"Acc Chem Res"},{"issue":"1","key":"2459_CR250","doi-asserted-by":"publisher","first-page":"19296","DOI":"10.1038\/s41598-020-76351-4","volume":"10","author":"AB Zaslavsky","year":"2020","unstructured":"Zaslavsky AB, Adams MP, Cao X, Maj T, Choi JE, Stangl-Kremser J, Patel S, Putelo A, Lee SK, Nallandhighal S, Kasputis A, Alva A, Lew M, Qin A, Mehra R, Morgan TM, Salami SS, Reichert Z, Udager A, Zou W, Palapattu GS (2020) Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors. Sci Rep 10(1):19296","journal-title":"Sci Rep"},{"key":"2459_CR251","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2024.114091","volume":"242","author":"W Ping","year":"2024","unstructured":"Ping W, Tang H, Dou H, Zhu D, Li X, Zhang N (2024) Biomimetic liposome amplifying mitochondrial damage to potential cancer radio-immunotherapy. Colloids Surf B Biointerfaces 242:114091","journal-title":"Colloids Surf B Biointerfaces"},{"key":"2459_CR252","doi-asserted-by":"crossref","first-page":"e013000","DOI":"10.1161\/CIRCINTERVENTIONS.122.013000","volume":"17","author":"CM Campos","year":"2024","unstructured":"Campos CM, Mehran R, Capodanno D, Owen R, Windecker S, Varenne O, Stone GW, Valgimigli M, Hajjar LA, Kalil Filho R, Oldroyd K, Morice MC, Urban P, Abizaid A (2024) Risk burden of cancer in patients treated with abbreviated dual antiplatelet therapy after PCI: analysis of multicenter controlled high-bleeding risk trials. Circ Cardiovasc Interv 17:e013000","journal-title":"Circ Cardiovasc Interv"},{"key":"2459_CR253","volume":"588","author":"Q Chen","year":"2024","unstructured":"Chen Q, Deng Y, Li Y, Chen J, Zhang R, Yang L, Guo R, Xing B, Ding P, Cai J, Zhao H (2024) Association of preoperative aspartate aminotransferase to platelet ratio index with outcomes and tumour microenvironment among colorectal cancer with liver metastases. Cancer Lett 588:216778","journal-title":"Cancer Lett"},{"key":"2459_CR254","doi-asserted-by":"crossref","first-page":"18044","DOI":"10.1002\/anie.202102206","volume":"60","author":"Y Hu","year":"2021","unstructured":"Hu Y, Ma VPY, Ma R, Chen W, Duan Y, Glazier R, Petrich BG, Li R, Salaita K (2021) DNA-based microparticle tension sensors (\u03bcTS) for measuring cell mechanics in non-planar geometries and for high-throughput quantification. Angew Chem Int Ed Engl 60:18044\u201318050","journal-title":"Angew Chem Int Ed Engl"},{"key":"2459_CR255","first-page":"2085","volume":"26","author":"YJ Ning","year":"2022","unstructured":"Ning YJ, Wan ZX, Meng J, Wang XP (2022) A systemic review and meta-analysis of the effects of perioperative anticoagulant and antiplatelet therapy on bleeding complications in robot-assisted prostatectomy. Eur Rev Med Pharmacol Sci 26:2085\u20132097","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2459_CR256","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ags3.12387","volume":"5","author":"H Ohya","year":"2020","unstructured":"Ohya H, Watanabe J, Suwa Y, Nakagawa K, Suwa H, Ozawa M, Ishibe A, Kunisaki C, Endo I (2020) Comparison of the continuation and discontinuation of perioperative antiplatelet therapy in laparoscopic surgery for colorectal cancer: a retrospective, multicenter, observational study (YCOG 1603). Ann Gastroenterol Surg 5:67\u201374","journal-title":"Ann Gastroenterol Surg"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02459-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-026-02459-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02459-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:41:37Z","timestamp":1792096897000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-026-02459-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":256,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["2459"],"URL":"https:\/\/doi.org\/10.1007\/s10495-026-02459-z","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]},"assertion":[{"value":"29 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"248"}}